<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Transpl Int</journal-id>
<journal-title>Transplant International</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Transpl Int</abbrev-journal-title>
<issn pub-type="epub">1432-2277</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">13992</article-id>
<article-id pub-id-type="doi">10.3389/ti.2025.13992</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Health Archive</subject>
<subj-group>
<subject>Systematic Review and Meta-Analysis</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Ethical Issues in Uncontrolled Donation After Circulatory Determination of Death: A Scoping Review to Reveal Areas of Broad Consensus, and Those for Future Research</article-title>
<alt-title alt-title-type="left-running-head">Georgiou et al.</alt-title>
<alt-title alt-title-type="right-running-head">uDCD Ethical Issues Scoping Review</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Georgiou</surname>
<given-names>Anastasia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2755222/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tan</surname>
<given-names>Weiyi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ionescu</surname>
<given-names>Mihnea I.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuhn</surname>
<given-names>Isla L.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2961091/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fritz</surname>
<given-names>Zoe</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2714205/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Clinical Medicine, University of Cambridge</institution>, <addr-line>Cambridge</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Miami Transplant Institute</institution>, <institution>Jackson Health System</institution>, <addr-line>Miami</addr-line>, <addr-line>FL</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>THIS (The Healthcare Improvement Studies) Institute, University of Cambridge</institution>, <addr-line>Cambridge</addr-line>, <country>United Kingdom</country>
</aff>
<author-notes>
<corresp id="c001">&#x2a;Correspondence: Zoe Fritz, <email>zbmf2@cam.ac.uk</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>02</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>38</volume>
<elocation-id>13992</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>01</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Georgiou, Tan, Ionescu, Kuhn and Fritz.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Georgiou, Tan, Ionescu, Kuhn and Fritz</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Uncontrolled donation after circulatory determination of death (uDCD) protocols are established in several countries with good outcomes. We reviewed the literature between 1997 and 2024 to identify ethical issues. 33 papers were identified. Several areas of continued ethical debate were delineated: the role of advanced life support techniques; the ethical acceptability of aortic occlusion balloons; the nature and timing of consent to organ preserving techniques; whether best interests can/should extend beyond individual bodily integrity in this context. Further empirical research and ethical analyses are needed in these domains. Broad consensus was identified on several issues including: decisions about termination of resuscitation and entry into a uDCD protocol should be made by different teams; at least 20&#x2013;30&#xa0;min of cardio-pulmonary resuscitation is required; a hands-off period of 5&#x2013;7&#xa0;min is required alongside continuous monitoring; organ preserving techniques should be as minimally invasive as possible; families should be approached early to discuss organ donation by trained staff; public knowledge and engagement about uDCD is poor and must be improved; transparency and informed consent are essential for potential uDCD organ recipients. To maintain transparency and encourage positive public engagement we propose a name change from uDCD to Organ Donation after Sudden Irreversible Cardiac Arrest (ODASICA).</p>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<graphic xlink:href="TI_ti-2025-13992_wc_abs.tif"/>
</p>
</abstract>
<kwd-group>
<kwd>transplant</kwd>
<kwd>uncontrolled donation</kwd>
<kwd>cardiac arrest</kwd>
<kwd>ethical considerations</kwd>
<kwd>systematic literature review</kwd>
</kwd-group>
<contract-num rid="cn001">TF093</contract-num>
<contract-num rid="cn002">208213/Z/17/Z</contract-num>
<contract-sponsor id="cn001">NHS Blood and Transplant<named-content content-type="fundref-id">10.13039/100009033</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Wellcome Trust<named-content content-type="fundref-id">10.13039/100010269</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Organ donation has widespread public support and can provide great comfort to families after the death of their loved ones [<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>]. However, only a small number become organ donors [<xref ref-type="bibr" rid="B4">4</xref>]. In the UK for example, less than 0.5% of people who die under the age of 80&#xa0;years become organ donors [<xref ref-type="bibr" rid="B4">4</xref>], a key reason for this being that there is no mechanism for people who die following out-of-hospital cardiac arrest to donate; only those who die in a &#x201c;controlled&#x201d; donation after circulatory death (cDCD) setting &#x2013; on an intensive care unit, with planned withdrawal of treatment and immediate organ recovery &#x2013; are eligible [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>].</p>
<p>So called &#x201c;uncontrolled&#x201d; donation after circulatory determination of death&#x2019; (uDCD) is possible in other countries after a witnessed cardiac arrest [<xref ref-type="bibr" rid="B7">7</xref>]. Cardio-pulmonary resuscitation (CPR) is started, and all efforts are made to revive the individual for at least 30&#xa0;min; this may include mechanical CPR which allows safe transport to hospital with ongoing regular compressions. Once in the hospital, the treating team assesses whether there are any further interventions which might be successful; if there are not, then, as with all cardiac arrests in which return of spontaneous circulation has not been achieved, CPR is stopped, and the patient is pronounced dead. There follows a hands-off period before the transplant team starts efforts to preserve the organs [<xref ref-type="bibr" rid="B8">8</xref>].</p>
<p>The challenge with uDCD is to ensure that, after the death of the patient, donor organs are rapidly preserved before they are irreversibly damaged due to ischemic injury while still providing sensitive care to donor families. In France and Spain, normothermic regional perfusion (NRP), a minimally invasive technique to preserve the organs <italic>in-situ</italic> after death, is used routinely to facilitate uDCD donation and the resulting kidney transplant outcomes have been excellent [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>].</p>
<p>uDCD has been introduced around Europe with notable success in France [<xref ref-type="bibr" rid="B11">11</xref>] and Spain [<xref ref-type="bibr" rid="B12">12</xref>]: around 1000 successful kidney transplants have been performed since 2015 [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B13">13</xref>]. It is also practiced in Italy [<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>] the Netherlands [<xref ref-type="bibr" rid="B16">16</xref>], Portugal [<xref ref-type="bibr" rid="B17">17</xref>], and Poland [<xref ref-type="bibr" rid="B18">18</xref>] and has been developed in Belgium [<xref ref-type="bibr" rid="B19">19</xref>], Russia [<xref ref-type="bibr" rid="B20">20</xref>], the US [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>], Taiwan [<xref ref-type="bibr" rid="B23">23</xref>] Korea [<xref ref-type="bibr" rid="B24">24</xref>], Austria [<xref ref-type="bibr" rid="B25">25</xref>] and the Czech Republic [<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>] with different protocols [<xref ref-type="bibr" rid="B28">28</xref>] and with varying degrees of success. Systematic reviews have examined specific elements of the process and the associated outcomes including of Extracorporeal Membrane Oxygenation (ECMO) [<xref ref-type="bibr" rid="B29">29</xref>], preservation techniques [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>] and graft outcomes [<xref ref-type="bibr" rid="B32">32</xref>].</p>
<p>Many overviews and editorials have been written on the challenges and ethical issues of both uDCD [<xref ref-type="bibr" rid="B33">33</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>] and cDCD [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>]. Most ethical issues emerge from establishing the best way to act in the patient&#x2019;s best interests when survival is no longer possible; there is perceived conflict between ensuring best end-of-life care and ensuring opportunity to donate organs. <xref ref-type="fig" rid="F1">Figure 1</xref> illustrates these points of conflict and ethical tension, alongside the uDCD process. See <xref ref-type="sec" rid="s12">Table SA</xref> in the supplementary materials for a full Glossary and abbreviations associated with uDCD.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>A visual representation of the ethical issues associated with uDCD. On the left, going from top to bottom, are the stages of a typical uDCD protocol in chronological order. On the right are the ethical issues associated with each stage. The numbers in brackets refer to the paragraph in which the issue is discussed. This figure was derived from our synthesis of the results in this paper.</p>
</caption>
<graphic xlink:href="ti-38-13992-g001.tif"/>
</fig>
<p>While many authors have identified ethical issues, there is insufficient empirical evidence or stakeholder engagement to develop a grounded understanding of normative claims, or what might be the &#x201c;right&#x201d; thing to do in several domains, particularly around conversations and consent. This contributes to a reluctance to initiate uDCD programs or even pilots, which itself creates an ethical issue given the shortage of organs for those who need them; around 5,000 people are waiting for a kidney transplant in the UK with an estimated 3 deaths per day are related to the shortage of donor organs [<xref ref-type="bibr" rid="B4">4</xref>], and over 100,000 are reported to be waiting in the USA [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B42">42</xref>]. A uDCD program is predicted to allow the recovery of a significant number of organs per year; to not explore this route would be to deny these patients a life-saving donation and to deny others the opportunity to donate.</p>
<p>There appears, therefore, to be an ethical imperative to explore conducting uDCD; the International liaison Committee on Resuscitation recently conducted a thorough review of international protocols and concluded that <italic>&#x201c;All health systems should develop, implement, and evaluate protocols designed to optimize organ donation opportunities for patients who have an out-of-hospital cardiac arrest and failed attempts at resuscitation</italic>&#x201d; [<xref ref-type="bibr" rid="B43">43</xref>] but teams doing so must be fully informed its associated ethical issues so that they can address them within their protocols. Previous work has systematically delineated some specific issues: Bastami et al collated evidence surrounding healthcare providers&#x2019; and the public&#x2019;s attitudes towards donation after cardiac death [<xref ref-type="bibr" rid="B44">44</xref>], Molina-Perez et al reviewed the role of families in deceased organ donation [<xref ref-type="bibr" rid="B45">45</xref>] and Schou et al reviewed ethical issues associated with extracorporeal life support [<xref ref-type="bibr" rid="B46">46</xref>] while Schiff et al have examined ethical issues associated with integrating ECMO and organ preservation in the USA [<xref ref-type="bibr" rid="B47">47</xref>]. However, there is no systematic review of original empirical studies or analyses on the ethical issues associated with uDCD.</p>
<p>We therefore undertook this review in order to (i) identify areas of ethical tension which need further research or stakeholder engagement and (ii) reveal areas of broad ethical consensus or empirical resolution. By doing this, we hope to be able to support those developing uDCD programs and direct researchers onto fertile ground.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec id="s2-1">
<title>Search</title>
<p>We systematically reviewed the literature for original, peer reviewed, articles on the ethical issues associated with uDCD.</p>
<p>MEDLINE via Ovid, Embase via Ovid, CINAHL via Ebsco, Scopus, PsycInfo via Ebsco, LexisNexis, WestLaw and Web of Science Core Collection were searched using the following MeSH terms or other subject terms, and synonyms. The full search strategy can be found in the <xref ref-type="sec" rid="s12">Supplementary Appendix</xref>, but can be summarized as: (1) out of hospital cardiac arrest terms OR uncontrolled AND (2) donation terms (adj5) AND (3) ethical OR legal terms The search was designed by a health librarian (IK) in collaboration with authors AG and ZF. Searches were run from 1st January 1997 until 1st April 2022 and re-run 30th May 2023 and again Sept 19th 2024. See <xref ref-type="fig" rid="F2">Figure 2</xref> for the PRISMA flow diagram.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>PRISMA diagram combining data from initial and rerun searches.</p>
</caption>
<graphic xlink:href="ti-38-13992-g002.tif"/>
</fig>
</sec>
<sec id="s2-2">
<title>Screening</title>
<p>9,920 papers in total (7,605 in 2022, 1,035 in 2023 and 1,280 in 2024) were screened for inclusion/ exclusion, using the criteria shown in <xref ref-type="table" rid="T1">Table 1</xref>. Three authors, AG, MI and ZF, performed screening. Each paper was blindly screened by two of the three screening authors using Rayyan. The inclusion and exclusion criteria were applied to the title and abstract, and where the outcome was ambiguous, the full publication was read in full by all three members of the screening team and discussed until conflict was resolved.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Inclusion and Exclusion criteria.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="center">Inclusion</th>
<th align="center">Exclusion</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Publication type</td>
<td align="left">&#x2022; Peer-reviewed<break/>&#x2022; Journal, article, or chapter<break/>&#x2022; Original analysis or data, e.g., original ethical analysis, empirical data pertaining to ethical issues about uDCD, or systematic ethical analysis<break/>&#x2022; English language<break/>&#x2022; Date from 01/01/1997 onward</td>
<td align="left">&#x2022; Not peer-reviewed<break/>&#x2022; Opinion piece, commentary, review<break/>&#x2022; No abstract<break/>&#x2022; Not original analysis nor data (review article)<break/>&#x2022; Systematic review (unless systematic ethical analysis)</td>
</tr>
<tr>
<td align="left">Publication content</td>
<td align="left">&#x2022; uDCD<break/>&#x2022; Ethics<break/>&#x2022; Law<break/>&#x2022; Policy analysis<break/>&#x2022; Protocol analysis</td>
<td align="left">&#x2022; cDCD only<break/>&#x2022; Pediatric (&#x3c;18 years) organ donation<break/>&#x2022; Non-human organ donation<break/>&#x2022; Ethical issues relating to cellular level research<break/>&#x2022; About process of donation only<break/>&#x2022; About outcomes of uDCD only</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>We included two kinds of papers:<list list-type="simple">
<list-item>
<p>1. Papers which presented original peer reviewed ethical analysis (where ethical analysis is defined as: identifying questions regarding what is the &#x201c;right&#x201d; thing to do (or what we ought not to do); critically and reflectively examining [<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>] different viewpoints; and presenting a reasoned argument, ideally with a normative conclusion of issues relating to uDCD) [<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>].</p>
</list-item>
<list-item>
<p>2. Papers which presented empirical data pertaining to ethical issues about uDCD, in particular, studies examining perceptions of uDCD.</p>
</list-item>
</list>
</p>
<p>Systematic reviews were excluded from the review, although these papers were read as a further way of identifying relevant papers. Reviews, commentaries and opinion pieces were excluded. Papers which reported protocols, outcomes or processes of donation without ethical analysis were excluded. The nature of the included papers can be seen in <xref ref-type="table" rid="T2">Table 2</xref>.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Publication characteristics of included papers.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="center">n/33</th>
<th align="center">%</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Country<break/>&#x2003;USA<break/>&#x2003;Canada<break/>&#x2003;UK<break/>&#x2003;Spain<break/>&#x2003;Switzerland<break/>&#x2003;Belgium<break/>&#x2003;Netherlands<break/>&#x2003;Italy<break/>&#x2003;Sweden<break/>&#x2003;Denmark<break/>&#x2003;Brazil</td>
<td align="center">16<break/>3<break/>3<break/>3<break/>2<break/>1<break/>1<break/>1<break/>1<break/>1<break/>1</td>
<td align="center">48<break/>9<break/>9<break/>9<break/>6<break/>3<break/>3<break/>3<break/>3<break/>3<break/>3</td>
</tr>
<tr>
<td align="left">Region<break/>&#x2003;North America<break/>&#x2003;Europe (continent)<break/>&#x2003;Other</td>
<td align="center">19<break/>13<break/>1</td>
<td align="center">58<break/>39<break/>3</td>
</tr>
<tr>
<td align="left">Publication type<break/>&#x2003;Systematic ethical analysis<break/>&#x2003;Primary ethical analysis<break/>&#x2003;Primary ethical and legal analysis<break/>&#x2003;Empirical analysis of public perception<break/>&#x2003;Empirical analysis of healthcare professional perception<break/>&#x2003;Empirical analysis of public and healthcare professional perception<break/>&#x2003;Empirical analysis of mass media campaigns<break/>&#x2003;Commentary on a protocol<break/>&#x2003;Primary ethical analysis and commentary on a protocol<break/>&#x2003;Case study, ethical and legal analysis</td>
<td align="center">1<break/>14<break/>3<break/>5<break/>2<break/>1<break/>1<break/>2<break/>3<break/>1</td>
<td align="center">3<break/>42<break/>9<break/>15<break/>6<break/>3<break/>3<break/>6<break/>9<break/>3</td>
</tr>
<tr>
<td align="left">Date of publication<break/>&#x2003;2001&#x2013;2010<break/>&#x2003;2011&#x2013;2020<break/>&#x2003;2021-May 2023</td>
<td align="center">8<break/>22<break/>3</td>
<td align="center">24<break/>67<break/>9</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-3">
<title>Second Screening</title>
<p>All papers included on the basis of title and abstract were read in full by authors AG, MI and ZF. The inclusion/ exclusion criteria were applied blindly by each member. A full team meeting was held to agree final includes.</p>
</sec>
<sec id="s2-4">
<title>Re-Runs of Search</title>
<p>The search was re-run in May 2023 using the same method as above, and again in October 2024 following peer review. A fourth member of the research team, author WT, read all papers included from both searches in full to ensure consistency of application of inclusion and exclusion criteria. Any conflicts were discussed and resolved as a team.</p>
</sec>
<sec id="s2-5">
<title>Quality Assessment</title>
<p>In alignment with the PRISMA guidelines for scoping reviews, an assessment of whether quality assessment would be appropriate was undertaken [<xref ref-type="bibr" rid="B52">52</xref>]. Given the wide range and nature of articles identified, a formal quality assessment of included studies was not performed [<xref ref-type="bibr" rid="B53">53</xref>].</p>
</sec>
<sec id="s2-6">
<title>Data Extraction and Analysis</title>
<p>The final included papers were read in full by authors AG and ZF and data was extracted.</p>
<p>A excel spreadsheet was created for extraction of data relating to both publication characteristics (title, date, author(s), country, article type, participants, limitations and content. Framework analysis was undertaken [<xref ref-type="bibr" rid="B54">54</xref>]: an initial coding framework was created based on themes identified in the background literature (see <xref ref-type="sec" rid="s12">Supplementary Appendix</xref> for data extraction proforma).</p>
<p>Having familiarized themselves with the data in each paper, and iterated the initial coding themes further, authors AG and ZF independently coded each paper.</p>
<p>Further themes were added upon data extraction and discussion among the authors, who together charted, mapped (see <xref ref-type="fig" rid="F1">Figure 1</xref>) and interpreted the data.</p>
<p>Some themes were grouped together for ease of understanding, with sub-themes being created. For example, the themes of &#x201c;consent&#x201d; and &#x201c;&#x2018;relatives&#x201d; were brought together under one heading, &#x201c;consent and involvement of next of kin,&#x201d; with two sub-themes, &#x201c;informed consent to the use of organ preserving techniques&#x201d; and &#x201c;the approach to discussion of organ donation with next of kin&#x201d; having emerged. In another example, &#x201c;optimisation and termination of resuscitation&#x201d; emerged as an important theme.</p>
<p>The final coding framework comprised seven broad ethical themes, along with subthemes. The frequency with which each ethical theme was raised in the literature was documented.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Publication Characteristics</title>
<p>33 papers were included. <xref ref-type="table" rid="T2">Table 2</xref> shows publication breakdown by country of origin, region, publication type and date.</p>
</sec>
<sec id="s3-2">
<title>Ethical Issues</title>
<p>7 broad ethical themes, along with subthemes, were identified. <xref ref-type="table" rid="T3">Table 3</xref> shows the proportion of papers addressing each issue. We explore each of these themes below and summarize the results in <xref ref-type="table" rid="T4">Table 4</xref>, highlighting areas of broad consensus and areas of ongoing ethical tension.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Proportion of papers addressing each ethical issue.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="4" align="left">Ethical issue</th>
<th align="center">n/33</th>
<th align="center">%</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="4" align="left">1</td>
<td rowspan="4" align="left">Optimization and termination of CPR, declaration of death and hands-off time</td>
<td align="center">1.1</td>
<td align="left">Conflicts of interest between treatment and transplant teams</td>
<td align="center">15</td>
<td align="center">45</td>
</tr>
<tr>
<td align="center">1.2</td>
<td align="left">Optimization and termination of resuscitation</td>
<td align="center">11</td>
<td align="center">33</td>
</tr>
<tr>
<td align="center">1.3</td>
<td align="left">Declaration of death</td>
<td align="center">15</td>
<td align="center">45</td>
</tr>
<tr>
<td align="center">1.4</td>
<td align="left">Hands-off time</td>
<td align="center">8</td>
<td align="center">24</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">The use of organ preserving techniques</td>
<td align="center"/>
<td align="left"/>
<td align="center">19</td>
<td align="center">58</td>
</tr>
<tr>
<td rowspan="2" align="left">3</td>
<td rowspan="2" align="left">Consent and involvement of next of kin</td>
<td align="center">3.1</td>
<td align="left">Informed consent to the use of organ preserving techniques</td>
<td align="center">17</td>
<td align="center">52</td>
</tr>
<tr>
<td align="center">3.2</td>
<td align="left">The approach to the discussion of organ donation with next of kin</td>
<td align="center">22</td>
<td align="center">67</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">Best interests, and whether this can extend beyond strict medical benefit</td>
<td align="center"/>
<td align="left"/>
<td align="center">8</td>
<td align="center">24</td>
</tr>
<tr>
<td rowspan="3" align="left">5</td>
<td rowspan="3" align="left">Societal responsibilities</td>
<td align="center">5.1</td>
<td align="left">Societal benefits of uDCD</td>
<td align="center">25</td>
<td align="center">76</td>
</tr>
<tr>
<td align="center">5.2</td>
<td align="left">Distributive justice</td>
<td align="center">6</td>
<td align="center">18</td>
</tr>
<tr>
<td align="center">5.3</td>
<td align="left">Resource cost</td>
<td align="center">11</td>
<td align="center">33</td>
</tr>
<tr>
<td rowspan="3" align="left">6</td>
<td rowspan="3" align="left">Public and professional knowledge, opinion, engagement and trust</td>
<td align="center">6.1</td>
<td align="left">Public understanding, education, and transparency</td>
<td align="center">21</td>
<td align="center">64</td>
</tr>
<tr>
<td align="center">6.2</td>
<td align="left">Public opinion and concerns about the uDCD process</td>
<td align="center">21</td>
<td align="center">64</td>
</tr>
<tr>
<td align="center">6.3</td>
<td align="left">Involvement and engagement</td>
<td align="center">23</td>
<td align="center">70</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">Informed consent to the receipt of organs from uDCD donors</td>
<td align="center"/>
<td align="left"/>
<td align="center">2</td>
<td align="center">6</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Summary of results.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="4" align="left">Ethical issue</th>
<th align="center">Areas of consensus</th>
<th align="center">Areas requiring further research</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="4" align="left">1</td>
<td rowspan="4" align="left">Optimization and termination of CPR, declaration of death and hands-off time</td>
<td align="center">
<italic>1.1</italic>
</td>
<td align="left">
<italic>Conflicts of interest between treatment and transplant teams</italic>
</td>
<td align="left">Decisions about TOR and uDCD entry should be made by different teams</td>
<td align="left">Ensuring true separation between teams</td>
</tr>
<tr>
<td align="center">
<italic>1.2</italic>
</td>
<td align="left">
<italic>Optimization and termination of resuscitation</italic>
</td>
<td align="left">At least 20&#x2013;30&#xa0;min of CPR.</td>
<td align="left">Factors precluding TOR.<break/>Location of TOR.<break/>Role of E-CPR/ ECMO.</td>
</tr>
<tr>
<td align="center">
<italic>1.3</italic>
</td>
<td align="left">
<italic>Declaration of death</italic>
</td>
<td align="left"/>
<td align="left">Standard of evidence of circulatory death</td>
</tr>
<tr>
<td align="center">
<italic>1.4</italic>
</td>
<td align="left">
<italic>Hands-off time</italic>
</td>
<td align="left">At least 5&#x2013;7&#xa0;min alongside continuous monitoring</td>
<td align="left"/>
</tr>
<tr>
<td align="left">2</td>
<td align="left">The use of OPTs</td>
<td align="center"/>
<td align="left"/>
<td align="left">The least invasive methods possible should be used</td>
<td align="left">Ethical acceptability of aortic occlusion balloons</td>
</tr>
<tr>
<td rowspan="2" align="left">3</td>
<td rowspan="2" align="left">Consent</td>
<td align="center">
<italic>3.1</italic>
</td>
<td align="left">
<italic>Informed consent to the use of OPTs</italic>
</td>
<td align="left"/>
<td align="left">Whether consent to OPTs is covered under general consent to donation<break/>Whether OPTs can be commenced prior to family consent</td>
</tr>
<tr>
<td align="center">
<italic>3.2</italic>
</td>
<td align="left">
<italic>The approach to the discussion of organ donation with next of kin</italic>
</td>
<td align="left">Families can be approached early, with sensitivity and respect and by trained staff</td>
<td align="left"/>
</tr>
<tr>
<td align="left">4</td>
<td align="left">Best interests</td>
<td align="center"/>
<td align="left"/>
<td align="left"/>
<td align="left">Whether best interests can be read widely at the population level to include wishes to donate</td>
</tr>
<tr>
<td rowspan="3" align="left">5</td>
<td rowspan="3" align="left">Societal responsibilities</td>
<td align="center">
<italic>5.1</italic>
</td>
<td align="left">
<italic>Societal benefits of uDCD</italic>
</td>
<td align="left">uDCD will increase the organ pool and has other psychosocial benefits</td>
<td align="left"/>
</tr>
<tr>
<td align="center">
<italic>5.2</italic>
</td>
<td align="left">
<italic>Distributive justice</italic>
</td>
<td align="left">uDCD organs must be recovered and distributed in an equitable way</td>
<td align="left">Ensuring equity of recovery and distribution</td>
</tr>
<tr>
<td align="center">
<italic>5.3</italic>
</td>
<td align="left">
<italic>Resource cost</italic>
</td>
<td align="left"/>
<td align="left">Short and long term financial and opportunity costs of uDCD.</td>
</tr>
<tr>
<td rowspan="3" align="left">6</td>
<td rowspan="3" align="left">Public and professional knowledge, opinion, engagement and trust</td>
<td align="center">
<italic>6.1</italic>
</td>
<td align="left">
<italic>Public understanding, education, and transparency</italic>
</td>
<td align="left">Public knowledge about uDCD is poor and must be improved via unbiased education</td>
<td align="left"/>
</tr>
<tr>
<td align="center">
<italic>6.2</italic>
</td>
<td align="left">
<italic>Public opinion and concerns about the uDCD process</italic>
</td>
<td align="left"/>
<td align="left">Public opinion on uDCD in different intersections of society<break/>Impact of uDCD on trust</td>
</tr>
<tr>
<td align="center">
<italic>6.3</italic>
</td>
<td align="left">
<italic>Involvement and engagement</italic>
</td>
<td align="left">Public education and stakeholder engagement is imperative<break/>Debate should be facilitated</td>
<td align="left"/>
</tr>
<tr>
<td align="left">7</td>
<td align="left">Informed consent to the receipt of organs from uDCD donors</td>
<td align="center"/>
<td align="left"/>
<td align="left">Transparency and informed consent are essential</td>
<td align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-3">
<title>Optimization and Termination of CPR, Declaration of Death and Hands-Off Time</title>
<p>An overarching ethical challenge that was identified throughout the literature was the perceived tension between maximizing the chances of successful resuscitation for the patient who has arrested and maintaining organ viability if resuscitative attempts were to fail.</p>
<sec sec-type="COI-statement" id="s3-3-1">
<title>Conflicts of Interest Between Treatment and Transplant Teams</title>
<p>Many authors recognized a potential for conflicts of interest (or perceived conflicts of interest) at several stages of the uDCD protocol; if one team, or several closely linked teams, make(s) decisions about resuscitation, termination of resuscitation (TOR), declaration of death and recruitment into the uDCD protocol, questions about the quality of resuscitation, whether all efforts were made to save the patient&#x2019;s life [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B55">55</xref>] and about financial incentives [<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>] are raised. Individual physicians may be placed in positions of conflict [<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>] and perceived conflict of interest can erode trust in the donation system and medical system more broadly [<xref ref-type="bibr" rid="B57">57</xref>]. These concerns are reflected in quantitative data: Goudet et al found that a majority of healthcare respondents in their multicenter survey thought there is conflict of interest between saving lives and saving organs in the uDCD context [<xref ref-type="bibr" rid="B58">58</xref>].</p>
<p>Many proposed separating the roles [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>] although it was recognized this would not eliminate conflict if the teams are in contact [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B21">21</xref>] and presents logistical and resource challenges [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>].</p>
</sec>
<sec id="s3-3-2">
<title>Optimization and Termination of Resuscitation</title>
<p>It was universally accepted that CPR should not be terminated until it was clear that continuing would be futile for the patient. There is insufficient research to recommend a specific duration of resuscitation [<xref ref-type="bibr" rid="B61">61</xref>] and no internationally accepted guidance [<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B61">61</xref>&#x2013;<xref ref-type="bibr" rid="B63">63</xref>] but most protocols mandate at least 20&#x2013;30&#xa0;min [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B22">22</xref>].</p>
<p>Beyond traditional attempted CPR, several authors considered the role of Extracorporeal CPR (E-CPR) and Extracorporeal Membrane Oxygenation (ECMO) to ensure that optimal CPR had been delivered before TOR. Authors questioned whether doctors might be choosing between attempting E-CPR/ECMO (or directing a patient towards a center that provided this) and consideration of donation (or directing a patient towards a center that delivered this). ECPR is not yet widely available and evidence of its efficacy in the out-of-hospital cardiac arrest setting is still being gathered [<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B63">63</xref>]. Authors questioned whether the inclusion criteria for ECMO/E-CPR and uDCD are sufficiently similar for there to be a conflict [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B64">64</xref>], whether allowing uDCD without ECMO/E-CPR may disincentivize development of the latter [<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>] and erode public trust [<xref ref-type="bibr" rid="B64">64</xref>] and whether insisting that all uDCD centers participate in ECMO/E-CPR practice or research will hinder donation, frustrate donor wishes [<xref ref-type="bibr" rid="B59">59</xref>] and create significant numbers of vegetative patients [<xref ref-type="bibr" rid="B65">65</xref>]. One of the included papers offered quantitative data; Goudet et al in their survey of 1057 hospital staff found that 20% of respondents thought that donation after circulatory death protocols should be suspended until precise indications for ECMO/E-CPR in refractory cardiac arrest have been defined [<xref ref-type="bibr" rid="B58">58</xref>].</p>
<p>There was consensus that TOR should be prohibited out of hospital while excluding reversible causes, i.e., if a shockable rhythm is present [<xref ref-type="bibr" rid="B8">8</xref>]. Ave et al went further, cautioning against TOR in non-shockable rhythms too as in the out-of-hospital cardiac arrest setting fine ventricular fibrillation and pulseless electrical activity could be missed; they considered the use of echocardiography at the hospital to rule this out [<xref ref-type="bibr" rid="B8">8</xref>]. Some protocols make TOR decisions upon arrival in the hospital [<xref ref-type="bibr" rid="B60">60</xref>], but some make them in the out of hospital setting, and then provide organ-preserving CPR during transit to the hospital [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B66">66</xref>] whereupon death will be declared. In these latter cases there are concerns that the quality of CPR might be &#x201c;subconsciously&#x201d; compromised during transport [<xref ref-type="bibr" rid="B61">61</xref>].</p>
</sec>
<sec id="s3-3-3">
<title>Declaration of Death</title>
<p>In the circulatory determination of death, it is said that death is being declared at the permanent stage and that irreversibility will rapidly and inevitably ensue as no methods aiming at resuscitation will be performed [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B67">67</xref>&#x2013;<xref ref-type="bibr" rid="B72">72</xref>]. Debate in terminology about declaration of death centers on these concepts of permanence (that circulation <italic>will</italic> not be restored) and irreversibility (that circulation <italic>cannot</italic> be restored); see <xref ref-type="sec" rid="s12">Supplementary Table SB</xref> for further details. Some authors suggested that declaration of death in possible donation circumstances may require a higher standard of evidence of circulatory cessation than in non-donation circumstances because the consequences are greater for the patient [<xref ref-type="bibr" rid="B68">68</xref>]. For example, rather than relying on mechanical asystole it may be necessary to prove absence of circulation via arterial line, arterial doppler or echocardiogram [<xref ref-type="bibr" rid="B8">8</xref>]. The approach varies considerably in different countries [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B71">71</xref>].</p>
<p>Conversely, some authors argued that declaration of death in the uDCD setting is less complex as by definition the patient will have undergone rigorous resuscitative efforts known to have failed [<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B69">69</xref>]. Survey data is inconclusive, with some studies associating donation after circulatory death with greater perceived certainty of death than Donation after Brainstem Death (DBD) [<xref ref-type="bibr" rid="B71">71</xref>] and others finding the opposite [<xref ref-type="bibr" rid="B70">70</xref>].</p>
<p>A common theme in the papers was to comment on logical and semantic inconsistencies that have emerged over the years as new definitions of death were introduced to facilitate new donation practices [<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B71">71</xref>] (in one case referred to as &#x201c;gerrymandering&#x201d; [<xref ref-type="bibr" rid="B65">65</xref>]); death was historically defined by cardiac, or circulatory, criteria and the concept of brain death was introduced in the 1960s to allow DBD. See <xref ref-type="sec" rid="s12">Supplementary Table SB</xref> for a summary of the changing definitions of death.</p>
<sec id="s3-3-3-1">
<title>Hands-Off Time</title>
<p>Debate about the length of hands-off time &#x2013; the period between termination of resuscitation, declaration of death, and initiation of insertion of cannulae for organ preservation &#x2013; focused on a tension between concerns about case reports of autoresuscitation (also known as Lazarus phenomenon) [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B68">68</xref>] and maximizing organ viability [<xref ref-type="bibr" rid="B59">59</xref>]; too short a period risks not giving opportunity for autoresuscitation and too long a period risks reduced organ viability.</p>
<p>Ave et al referenced Hornby&#x2019;s systematic review of case reports of autoresuscitation: they are small in number, and most have occurred at under 5&#xa0;min; those that occurred after that did so in the absence of continuous monitoring [<xref ref-type="bibr" rid="B8">8</xref>]. In view of this, Parent et al concluded that risks of autoresuscitation after 10&#xa0;min are extremely low, and continuous monitoring would pick up those that occurred [<xref ref-type="bibr" rid="B59">59</xref>].</p>
<p>France and Spain have a hands-off period of 5&#xa0;min [<xref ref-type="bibr" rid="B8">8</xref>]; Goudet et al, based on a survey of healthcare professionals, suggested a minimum of 2&#x2013;5&#xa0;min no touch time is necessary [<xref ref-type="bibr" rid="B58">58</xref>].</p>
</sec>
</sec>
</sec>
<sec id="s3-4">
<title>The Use of Organ Preserving Techniques</title>
<p>Once death has been declared, and a hands-off period observed, organ preserving techniques (OPTs) are instigated. Broad ethical issues include risk of resuming brain circulation [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B73">73</xref>] and retroactively negating declaration of death [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B70">70</xref>], violation of bodily integrity [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B74">74</xref>], resource cost [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B72">72</xref>] and stress for the treating physicians [<xref ref-type="bibr" rid="B8">8</xref>].</p>
<p>Violation of bodily integrity was the most cited with a common theme: there was consensus that the least invasive methods possible should be used to preserve the opportunity to donate [<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B74">74</xref>&#x2013;<xref ref-type="bibr" rid="B76">76</xref>]. Bruce et al&#x2019;s study of emergency department (ED) patients and relatives found that a majority felt that insertion of groin tubes, CPR and ventilation were acceptable as OPTs, if there was as little invasion of the body as possible [<xref ref-type="bibr" rid="B75">75</xref>] and Goudet et al&#x2019;s survey found that majority of respondents did not consider cannulation as a &#x201c;bodily integrity alteration&#x201d; [<xref ref-type="bibr" rid="B58">58</xref>]. Volk et al also found support for OPTs; 80% of their participants expressed support for a rapid organ recovery where they live [<xref ref-type="bibr" rid="B57">57</xref>].</p>
<p>Many authors commented on the ethical issues raised by specific techniques. Use of NRP (ECMO to perfuse the organs only) is defended by some [<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B72">72</xref>] as an essential means of preserving donation opportunity with good outcomes for kidneys [<xref ref-type="bibr" rid="B65">65</xref>] but specifically opposed by others [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B69">69</xref>]. Use of an aortic occlusion balloon was described by some as a responsible method of facilitating organ preservation whilst preventing perfusion of the brain [<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B77">77</xref>] while others were concerned that it might render a physician complicit in a patient&#x2019;s death [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B70">70</xref>]. Use of cold preservation solution was opposed by two authors for reasons of poorer outcomes [<xref ref-type="bibr" rid="B65">65</xref>] and interference with determination of death [<xref ref-type="bibr" rid="B8">8</xref>] but supported by others as it carries less risk of brain reanimation [<xref ref-type="bibr" rid="B68">68</xref>]. Dubois et al in their survey of 70 members of the public found that 72% expressed support of a law permitting organ cooling in order to preserve organs [<xref ref-type="bibr" rid="B78">78</xref>].</p>
</sec>
<sec id="s3-5">
<title>Consent and Involvement of Next of Kin</title>
<p>Given the time pressures of instigating OPTs, several authors explored the issues with consent, and attempted to determine the optimal timing, place, and content for conversations with relatives of the deceased which are both respectful of autonomy and compassionate. Volk et al found that hypothetical family consent to donation in uDCD settings was high [69% (95% CI 65%&#x2013;73%)] when compared with cDCD [70% (95% CI 66%&#x2013;75%)] and DBD [66% (95% CI 62&#x2013;71)], however that participants were less confident in making donation decisions about a relative when compared with themselves (71% and 75% respectively) [<xref ref-type="bibr" rid="B57">57</xref>].</p>
<sec id="s3-5-1">
<title>Informed Consent to the Use of OPTs</title>
<p>While some authors argued that consent for OPTs is covered under general consent for donation [<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B79">79</xref>], most felt it was not: authors argued most frequently that the public are not well enough informed about what OPTs involve [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B80">80</xref>] and, to a lesser extent, that OPTs are not done strictly for the patient&#x2019;s direct benefit [<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B80">80</xref>] and that people&#x2019;s views on OPTs may be too nuanced to be summarized in one binary decision [<xref ref-type="bibr" rid="B81">81</xref>]. Several authors therefore proposed that specific consent was needed for OPTs given that they damage bodily integrity [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B58">58</xref>] and could potentially violate patient autonomy [<xref ref-type="bibr" rid="B58">58</xref>].</p>
<p>Four papers provided survey data on the need for and optimal timing of family consent for OPTs (see <xref ref-type="table" rid="T5">Table 5</xref>) [<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B78">78</xref>]; a slim majority in three papers felt it was acceptable to proceed with OPT prior to family consent, but only 17% of participants in Volk&#x2019;s 2010 study thought it was acceptable to proceed &#x201c;in the absence of family consent or a known donor card&#x201d; [<xref ref-type="bibr" rid="B57">57</xref>]; this study took place in the setting of an &#x201c;opt in&#x201d; system.</p>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Survey results on the acceptability of commencement of OPTs prior to gaining family consent.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="center">Commencement of OPTs while family consent is being sought IS acceptable</th>
<th align="center">Commencement of OPTs while family consent is being sought is NOT acceptable</th>
<th align="center">Unsure</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Dubois et al [<xref ref-type="bibr" rid="B78">78</xref>]</td>
<td align="left">49%</td>
<td align="left">39%</td>
<td align="left">12%</td>
</tr>
<tr>
<td align="left">Goudet et al [<xref ref-type="bibr" rid="B58">58</xref>]</td>
<td align="left">46.8%</td>
<td align="left">42.5%</td>
<td align="left">10/7%</td>
</tr>
<tr>
<td align="left">Volk et al [<xref ref-type="bibr" rid="B57">57</xref>]</td>
<td align="left">17% (95% CI 13%&#x2013;20%)</td>
<td align="left">Not available</td>
<td align="left">Not available</td>
</tr>
<tr>
<td align="left">Bruce et al [<xref ref-type="bibr" rid="B75">75</xref>]</td>
<td align="left">48% (groin tube), 51% (CPR), 57% (ventilator)</td>
<td align="left">28% (groin tube), 24% (CPR), 21% (ventilator)</td>
<td align="left">24% (groin tube), 25% (CPR), 22% (ventilator)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In support of commencing OPTs prior to family consent were arguments that OPTs in uDCD are no more invasive than interventions done in the DBD setting [<xref ref-type="bibr" rid="B74">74</xref>], that it is the only way to preserve the family&#x2019;s opportunity to make their own decision [<xref ref-type="bibr" rid="B79">79</xref>] and that to do otherwise renders protocols logistically impossible [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B73">73</xref>]. Light et al and Wall et al reflected on their experiences in Washington, D.C. and New York respectively in which the requirement for family consent was the main barrier to success [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B67">67</xref>]. Other authors supported use of OPTs prior to family consent but only if the techniques are minimally invasive [<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B82">82</xref>]. Some argued strongly for the opposite: that OPTs should only be applied once both donor consent <italic>and</italic> family consent have been confirmed [<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B69">69</xref>]. Arguments for this approach included reducing mistrust [<xref ref-type="bibr" rid="B78">78</xref>], respect for autonomy [<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B83">83</xref>], reduction of resource cost [<xref ref-type="bibr" rid="B83">83</xref>] and reduction of family distress [<xref ref-type="bibr" rid="B60">60</xref>].</p>
<p>Two alternative systems were suggested: Moorlock et al proposed a detailed anticipatory consent form with which people can learn about and communicate their nuanced views on the complexities of OPTs [<xref ref-type="bibr" rid="B81">81</xref>] and Verheijde et al questioned whether a system of mandated informed decision making would be best [<xref ref-type="bibr" rid="B63">63</xref>]. These models for anticipatory specific consent would overcome concerns that specific consent for OPTs would render uDCD protocols logistically unworkable in an emergency setting [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B76">76</xref>] thus reducing the number of available donors.</p>
</sec>
<sec id="s3-5-2">
<title>The Approach to the Discussion of Organ Donation With Next of Kin</title>
<p>Most papers found an acceptance for conversations about donation with next of kin to happen early in the acute setting. Wall et al described that, in the New York protocol, families were not offended by being asked soon after witnessing their loved one&#x2019;s unexpected death [<xref ref-type="bibr" rid="B67">67</xref>]. Bruce et al, in their study of 200 members of the public, found that most people (54%) were willing to discuss donation soon after death in the ED [<xref ref-type="bibr" rid="B75">75</xref>], and that there is no difference in the number willing to discuss donation after circulatory death in ED (as is the case in uDCD) compared with brain death in ITU (72% in both cases, p &#x3d; 0.146) [<xref ref-type="bibr" rid="B75">75</xref>]. Consistent with this, Wind et al found that consent rates were higher in patients who had an unexpected death than in those who had an expected death (61% and 45% respectively, P &#x3d; 0.007) [<xref ref-type="bibr" rid="B82">82</xref>]. These empirical studies go some way to addressing Light&#x2019;s concerns that it may be hard for families to cope with a sudden loss and the question of donation at the same time [<xref ref-type="bibr" rid="B22">22</xref>], although time constraints in contacting families may present a logistical barrier [<xref ref-type="bibr" rid="B22">22</xref>].</p>
<p>There was consensus that families should be approached with sensitivity and respect, by staff with specialist training [<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B80">80</xref>].</p>
</sec>
</sec>
<sec id="s3-6">
<title>Best Interests, and Whether This Can Extend Beyond Strict Medical Benefit</title>
<p>In uDCD protocols the patient will lack capacity and decisions must be made in their best interest [<xref ref-type="bibr" rid="B84">84</xref>, <xref ref-type="bibr" rid="B85">85</xref>]. Best interests decisions must be made on a case-by-case basis [<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>], but often little is known about the individual&#x2019;s desires in the emergency situation: best interests decisions are therefore based in the first instance on population level knowledge.</p>
<p>If the concept of best interests is taken in its narrow, medical sense, uDCD becomes ethically challenging because OPTs are invasive and done beyond the point at which there will be medical benefit to the patient. Potential harms to the patient are physical [<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B80">80</xref>], and non-physical e.g., treating the patient as a means to an end [<xref ref-type="bibr" rid="B73">73</xref>], violation of a deep desire to not donate [<xref ref-type="bibr" rid="B73">73</xref>], distress to the family [<xref ref-type="bibr" rid="B80">80</xref>], and impact on the dignity of a person [<xref ref-type="bibr" rid="B62">62</xref>]. Moorlock et al and De Lora et al questioned whether any harm can be inflicted on a nearly dead patient [<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>] but concluded that there is a duty to treat cadavers with respect [<xref ref-type="bibr" rid="B80">80</xref>], and that respect for dead persons and posthumous wishes is an established ethical concept [<xref ref-type="bibr" rid="B81">81</xref>].</p>
<p>Several authors suggested that best interests should be interpreted more broadly than considering physical integrity [<xref ref-type="bibr" rid="B72">72</xref>]. Arguments included that best interests are now accepted as extending beyond the strictly clinical [<xref ref-type="bibr" rid="B80">80</xref>] and include fulfillment of wishes to donate [<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B80">80</xref>], promotion of dignity for example by &#x201c;favoring the accomplishment of their life project&#x201d; to donate [<xref ref-type="bibr" rid="B62">62</xref>] and permitting altruism in end of life planning [<xref ref-type="bibr" rid="B73">73</xref>]. OPT may preserve the family&#x2019;s opportunity to make their own informed decision about donation [<xref ref-type="bibr" rid="B80">80</xref>] and preserve the autonomy of those patients who turn out to have expressed wishes to donate [<xref ref-type="bibr" rid="B72">72</xref>]. Without OPTs, the opportunity to donate is lost [<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B78">78</xref>].</p>
</sec>
<sec id="s3-7">
<title>Societal Responsibilities</title>
<p>Several papers considered the ethical duty to consider responsibilities to society as well as to the individual.</p>
<sec id="s3-7-1">
<title>Societal Benefits of uDCD</title>
<p>The most frequently raised benefit was the increased number of organs [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B57">57</xref>&#x2013;<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B65">65</xref>&#x2013;<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B74">74</xref>&#x2013;<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B83">83</xref>] and therefore reduced morbidity and mortality, which is widely seen as a &#x201c;societal good&#x201d; [<xref ref-type="bibr" rid="B74">74</xref>] with only one of the included papers disagreeing [<xref ref-type="bibr" rid="B63">63</xref>]. Several papers give data on the organ pool, providing international evidence of the potential benefit of introducing a uDCD program [<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B78">78</xref>].</p>
<p>Other societal benefits may include psychosocial benefits [<xref ref-type="bibr" rid="B73">73</xref>], comfort to grieving families [<xref ref-type="bibr" rid="B73">73</xref>], reduction in coercive or illegal organ practices if more legitimate organs are available [<xref ref-type="bibr" rid="B66">66</xref>], and economic benefits through taking patients off costly dialysis [<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>] and returning them to economic activity [<xref ref-type="bibr" rid="B73">73</xref>].</p>
</sec>
<sec id="s3-7-2">
<title>Distributive Justice</title>
<p>Several papers addressed concerns that organs may be recovered and distributed in an inequitable way on the uDCD pathway. It was noted that uDCD is likely to be disproportionately available in large inner-city hospitals [<xref ref-type="bibr" rid="B64">64</xref>] and that these usually serve socioeconomically disadvantaged populations [<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B64">64</xref>] in which cardiac arrest [<xref ref-type="bibr" rid="B61">61</xref>] and violent or traumatic injury [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B64">64</xref>] is more common. Authors commented on the disproportionate representation of ethnic minorities in donor populations [<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B64">64</xref>], resulting in complaints that the system is biased [<xref ref-type="bibr" rid="B55">55</xref>], and on minority group members expressing significant mistrust and suspicion toward organ donation [<xref ref-type="bibr" rid="B64">64</xref>]. Moorlock et al noted that uptake of advance care planning has been found to be lower among older people from ethnic minorities [<xref ref-type="bibr" rid="B81">81</xref>] and questioned whether their own proposal to introduce a comprehensive consent form would exacerbate existing inequalities in organ donation.</p>
<p>Ave et al argued that socioeconomically advantaged patients who have better access to health resources may be more likely to receive a uDCD transplant [<xref ref-type="bibr" rid="B61">61</xref>], and a case of perceived unjust allocation of organs to a wealthy, prominent figure was noted [<xref ref-type="bibr" rid="B64">64</xref>]. In contrast, Wall et al discussed data showing that underserved communities are disproportionately affected by conditions leading to renal failure and therefore receive more organs [<xref ref-type="bibr" rid="B66">66</xref>]. Allocation by age of recipient was raised by Light et al; they noted that recent moves to use expanded criteria donors have not benefitted younger, healthier recipients, only older ones, but that uDCD programs may.</p>
</sec>
<sec id="s3-7-3">
<title>Resource Cost</title>
<p>uDCD protocols are highly resource intensive [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B86">86</xref>] in view of the equipment, personnel [<xref ref-type="bibr" rid="B60">60</xref>], transport [<xref ref-type="bibr" rid="B8">8</xref>] and training costs. The opportunity costs (for example in ambulances being unavailable for other sick patients because they are being used to transport patients into ED who might otherwise have been declared dead out of hospital [<xref ref-type="bibr" rid="B69">69</xref>]) associated with a uDCD program are significant although not universal and would vary depending on individual center capacities [<xref ref-type="bibr" rid="B73">73</xref>]. Some papers discussed ideas for mitigating opportunity costs, for example having separate ambulances for potential donors [<xref ref-type="bibr" rid="B83">83</xref>] or limiting uDCD to in-hospital settings only [<xref ref-type="bibr" rid="B69">69</xref>]. Several authors postulated that the overall uDCD costs would be mitigated in the long term with fewer patients on dialysis [<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B73">73</xref>] and with the development of economies of scale as projects expand [<xref ref-type="bibr" rid="B66">66</xref>].</p>
</sec>
</sec>
<sec id="s3-8">
<title>Public and Professional Knowledge, Opinion, Engagement and Trust</title>
<p>Public and clinician trust in organ donation and in the wider medical system is imperative and links to our societal responsibilities [<xref ref-type="bibr" rid="B64">64</xref>]. If people do not trust the system they are less likely to donate and support transplantation as a whole [<xref ref-type="bibr" rid="B69">69</xref>].</p>
<sec id="s3-8-1">
<title>Public Understanding, Education and Transparency</title>
<p>Several authors reported that current public understanding of uDCD is poor [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B86">86</xref>] and that uDCD protocols can differ substantially from common ideas of what donation involves [<xref ref-type="bibr" rid="B8">8</xref>]. In France and Spain no program of public information was conducted; the opt-out system was introduced without data on public opinion [<xref ref-type="bibr" rid="B8">8</xref>]. Bednecko et al found that 60% of their participants in Brazil didn&#x2019;t know about donation legislation [<xref ref-type="bibr" rid="B86">86</xref>], and Goudet et al found that a majority of their survey participants in France considered the paucity of public information to be unacceptable and possibly reflective of concerns the medical community itself has about uDCD [<xref ref-type="bibr" rid="B59">59</xref>].</p>
<p>Most authors agreed that more substantial public information is needed [<xref ref-type="bibr" rid="B58">58</xref>]. Understanding allows people to make informed autonomous decisions [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B80">80</xref>], helps to avoid mistrust in the system [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B64">64</xref>], ensures that policies are ethically acceptable [<xref ref-type="bibr" rid="B80">80</xref>], improves enrollment rates [<xref ref-type="bibr" rid="B66">66</xref>] and may even reduce illegal organ trade [<xref ref-type="bibr" rid="B66">66</xref>]. Education must be transparent and accurate [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B72">72</xref>], comprehensive [<xref ref-type="bibr" rid="B59">59</xref>], be directed toward the local community [<xref ref-type="bibr" rid="B64">64</xref>], include information on how to opt-out [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>], and be deliverable through diverse media [<xref ref-type="bibr" rid="B22">22</xref>].</p>
<p>Rady et al emphasized the difference between education (providing information) and propaganda (communicating with a view to influence) and suggested separation of the governmental agency responsible for organ transplantation practice from the agency responsible for organ donation campaigns [<xref ref-type="bibr" rid="B56">56</xref>]. They based this proposal on concerns about bias, inaccuracy, misinformation, and undeclared conflicts of interests perceived in other campaigns [<xref ref-type="bibr" rid="B56">56</xref>] and a noted discrepancy between controversies happening in the scientific communities, and public messages which suggest no such controversies exist [<xref ref-type="bibr" rid="B70">70</xref>]. Moorlock et al&#x2019;s proposal involves integrating education materials and specific elements of consent [<xref ref-type="bibr" rid="B81">81</xref>].</p>
</sec>
<sec id="s3-8-2">
<title>Public Opinion and Concerns About the uDCD Process</title>
<p>Several papers provided empirical data on opinions toward uDCD, with four finding equal support [<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B75">75</xref>], and two finding less support for uDCD than other types of donation [<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B86">86</xref>].</p>
<p>uDCD protocols have potential to engender mistrust due to the use of OPTs without consent [<xref ref-type="bibr" rid="B78">78</xref>], concerns that the patient may not actually be dead [<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B72">72</xref>] and that there is violation of the prohibition against interfering with a dead body [<xref ref-type="bibr" rid="B66">66</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B83">83</xref>]. Several authors raised that mistrust is disproportionately felt by ethnic minorities [<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B78">78</xref>]. Perceived conflict of interest between treatment and donation can cause mistrust toward, and between, healthcare professionals [<xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>] owing to the perception that organ donors may receive less aggressive life-saving care [<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B73">73</xref>], although Volk et al&#x2019;s study reported that &#x201c;the idea of a rapid organ recovery program did not significantly increase fears that signing an organ donor card would make doctors not try as hard to save their life&#x201d; [<xref ref-type="bibr" rid="B57">57</xref>].</p>
</sec>
<sec id="s3-8-3">
<title>Involvement and Engagement</title>
<p>Most authors agreed that, in order to achieve transparency, accountability [<xref ref-type="bibr" rid="B64">64</xref>], and sustainable program success [<xref ref-type="bibr" rid="B67">67</xref>] numerous stakeholders must be consulted, including the government, the transplant network, public health, medical and ethical communities, the public [<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B65">65</xref>], secular and religious community organizations [<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B71">71</xref>], community boards representing multi-ethnic populations [<xref ref-type="bibr" rid="B66">66</xref>], emergency practitioners [<xref ref-type="bibr" rid="B49">49</xref>] and specific local stakeholders [<xref ref-type="bibr" rid="B73">73</xref>]. Several authors also suggested that open and clear debate among both healthcare professionals and the public should be facilitated [<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B83">83</xref>], and Dubois et al raised the importance of monitoring uDCD protocols, suggesting that review boards be set up to assess adherence to policy and ensure accountability [<xref ref-type="bibr" rid="B78">78</xref>].</p>
<p>Delora et al explored how the mandate for uDCD protocols is established. They delineate the difference between allowing the initiation of OPTs on the basis of presumed consent via parliament legislation, as was the case in the Netherlands [<xref ref-type="bibr" rid="B80">80</xref>], and via governmental decree, as was the case in Spain [<xref ref-type="bibr" rid="B80">80</xref>]. The former involves democratic, accountable debate whereas the latter does not [<xref ref-type="bibr" rid="B80">80</xref>].</p>
</sec>
</sec>
<sec id="s3-9">
<title>Informed Consent to the Receipt of Organs From uDCD Donors</title>
<p>Finally, two of the included papers raised the issue of how recipients of organs procured via uDCD should be consented for a transplant [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B76">76</xref>] and how much information they should be given on the source of the organ. Data suggests that the long-term outcomes of organs transplanted in uDCD protocols are as good as those transplanted in DBD protocols [<xref ref-type="bibr" rid="B62">62</xref>] and in cDCD protocols [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B59">59</xref>] however there is evidence to suggest that there is a higher rate of shorter term complication, i.e., delayed graft function in uDCD [<xref ref-type="bibr" rid="B8">8</xref>]. Transparency and informed consent are essential, particularly in areas where uDCD is in development.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>We have reviewed the literature on uDCD and identified areas of broad consensus and areas of ongoing ethical tension. Teams proceeding in piloting uDCD protocols, should do so with concurrent outcome and ethical evaluation. Several issues require further analysis; we will focus on four with reference to wider empirical, philosophical, and ethical literature.</p>
<sec id="s4-1">
<title>Optimizing Outcomes for the Individual and for the Organs</title>
<p>In attempting CPR, the primary intention is to regain spontaneous circulation and neurological recovery for the patient [<xref ref-type="bibr" rid="B87">87</xref>]; a secondary effect is optimal perfusion of the organs for transplantation should CPR be stopped. In transferring a patient to hospital, the primary intention is to ensure a comprehensive assessment of the irreversibility of the condition; a secondary effect is ensuring efficient organ recovery should CPR be stopped. Therefore, by optimizing CPR and transferring an arrest patient to hospital, the treating team is both optimizing patient outcomes and organ viability; they are not choosing one over the other [<xref ref-type="bibr" rid="B88">88</xref>].</p>
<p>Further, once CPR is stopped, 5&#xa0;min of hands-off time followed by 5&#xa0;min of continuous monitoring while cannulating results in a total of 10&#xa0;min before the aortic occlusion balloon is inflated and NRP started. While case studies of autoresuscitation have been reported after termination after CPR, most are associated with confounders and a recent systematic reviews showed that it is extremely rare for them to take place after 10&#xa0;min; none have occurred in the situation being proposed, with continuous monitoring for 5&#xa0;min [<xref ref-type="bibr" rid="B89">89</xref>&#x2013;<xref ref-type="bibr" rid="B91">91</xref>].</p>
<p>Some caveats do remain. First, we found consensus that decisions about TOR and entry into a uDCD protocol should be made by different teams; research into the logistics and outcomes of this is needed. Second, we found disagreement over whether the level of resuscitation should extend beyond advanced life support to ECMO/E-CPR; more research is needed into the benefits of these techniques in the out-of-hospital cardiac arrest setting and the impact that having uDCD without ECMO/ E-CPR may have on outcomes and on community trust.</p>
</sec>
<sec id="s4-2">
<title>Best Interests Can Extend Beyond an Individual&#x2019;s Lifetime</title>
<p>Authors of the included papers disagreed whether best interests in the uDCD context extend beyond the strictly clinical and beyond the individual&#x2019;s lifetime. UK law supports a broad reading of best interests, and in the cDCD debate it has been argued that &#x201c;where a patient would wish to donate, measures [that] are necessary for organ donation to proceed &#x2026; serve, rather than deny, the best interests of a patient&#x201d; [<xref ref-type="bibr" rid="B92">92</xref>] and are therefore autonomy respecting. The difficulty is that within an opt out system (and without Moorlock and Draper&#x2019;s ambitious proposal of mandated anticipatory consent) [<xref ref-type="bibr" rid="B81">81</xref>], the specific wishes of most individuals are not known.</p>
<p>Although best interest decisions are, by definition, person specific, they are often initially made on population level knowledge. For example, a person found in cardiac arrest will be subject to CPR while further information on their wishes is sought [<xref ref-type="bibr" rid="B93">93</xref>]. This logic can reasonably be applied in the donation setting given that a majority of the population &#x2013; with the information currently available to them &#x2013; would like to donate [<xref ref-type="bibr" rid="B2">2</xref>]; while information is being sought about a person&#x2019;s wishes, it may be in their best interests to cannulate and start NRP to preserve opportunity for donation.</p>
</sec>
<sec id="s4-3">
<title>The Role of the Aortic Occlusion Balloon</title>
<p>There has been significant discussion about the role of the aortic occlusion balloon in All forms of DCD [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B95">95</xref>]; this discussion is intimately associated with the definition of death [<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B96">96</xref>], and the philosophical debate around the ethical relationship between acts and omissions [<xref ref-type="bibr" rid="B97">97</xref>].</p>
<p>The device is required because a secondary effect of starting NRP is to resupply blood and oxygen to the brain to the same level of the attempted CPR. There is no evidence that this level of recirculation is likely to facilitate awareness or pain, but it is impossible to say for certain that there is no perception. Therefore, to avoid an unintended harm, the aortic occlusion balloon is inserted to prevent all circulation to the brain and maintain a peaceful death.</p>
<p>A recent prospective study by <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/?term=Royo-Villanova+M&#x26;cauthor_id=37739346">Royo-Villanova</ext-link> et al showed that when the thoracic aorta was blocked with an aortic occlusion balloon the mean intracranial arterial blood pressure at the circle of Willis was the same during circulatory arrest as it was following NRP being started, confirming that this technique works to stop brain perfusion [<xref ref-type="bibr" rid="B98">98</xref>]; this study should provide reassurances to those to those who were concerned about the efficacy of the aortic occlusion balloon.</p>
<p>Some have expressed concern that insertion of an aortic occlusion balloon in order to block circulation to the brain is itself an act which hastens death [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B68">68</xref>]. In the cases we are considering, however, the patient has already died; their heart has stopped, there has been no responsiveness with CPR, and a multidisciplinary team has recognized the futility of further efforts. We agree with Schiff et al who say: &#x201c;this is similar to <italic>ex vivo</italic> perfusion, in which perfusion is restored to the recovered organ to increase transplant viability, while the process towards loss of brain function in the donor body is allowed to continue.&#x201d; [<xref ref-type="bibr" rid="B47">47</xref>] On this view, the aortic occlusion balloon is acting to minimize harm, while maximizing the individuals&#x2019; potential to donate.</p>
</sec>
<sec id="s4-4">
<title>Transparency and Public Engagement</title>
<p>The above conclusions - namely that the interests of both resuscitation and donation can be simultaneously respected; that best interests apply posthumously and can be read broadly; and that an aortic occlusion balloon is in a patient&#x2019;s best interests &#x2013; are contingent on transparency and public engagement [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B99">99</xref>]. If population level data is to be used to inform initial presumptions about what is in a patient&#x2019;s best interests, public attitudes must be regularly surveyed and assumptions cannot be made [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B83">83</xref>].</p>
<p>There is some nervousness surrounding public discussion of the details of uDCD. While public attitudes toward donation are predominantly positive, there is an awareness that one bad media story can change views and potentially cost lives if it results in people opting out [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>]. The risks are increased when - as needs to be done - relatives are being asked to consent not only for transplant but for research into a new way of undertaking transplant. This nervousness is justified given the stakes, but it is a reason for ensuring that information about transplantation is understandable and widely available; hiding information is much more likely to erode trust in the long term. We should borrow from the World Health Organization&#x2019;s advice on transparency in public health emergencies: information must be <italic>&#x201c;factually accurate, easily understood by the intended audience and presented in a manner that promotes adoption of the desired behaviors&#x201d;</italic> and we <italic>must &#x201c;promote trust by being forthcoming and open</italic> &#x2026;, <italic>including the evidence and assumptions used by authorities in making decisions, the manner in which those decisions are being made and by whom.&#x201d;</italic> [<xref ref-type="bibr" rid="B100">100</xref>]</p>
<p>Finally, if public engagement and trust are to be sought, an alternative name to &#x201c;Uncontrolled Donation after Cardiac Death&#x201d; should be considered. The name derives from differentiating it from the controlled setting of an intensive care unit with planned withdrawal of treatment, but to those who don&#x2019;t know this history, the term &#x201c;uncontrolled&#x201d; implies chaos and lack of regulation. As O&#x2019;Rourke et al state, &#x201c;who would wish to be involved in an &#x201c;uncontrolled process&#x201d;?&#x201d; [<xref ref-type="bibr" rid="B101">101</xref>] A name that clearly describes the practice could be considered: Organ Donation After Sudden Irreversible Cardiac Arrest (ODASICA), or some other clearly descriptive explanation, may go some way towards engaging the public.</p>
</sec>
</sec>
<sec id="s5">
<title>Strengths and Limitations</title>
<p>We conducted a scoping review of the literature: the selection of papers was systematic, and blinded. Data was extracted on a standardized template and more than two authors read each paper to ensure agreement on the relevant themes.</p>
<p>Our study has limitations. There is some subjectivity in determining the difference between a review article and one which provides &#x201c;original ethical analysis&#x201d; of uDCD; we chose not to include review, opinion or comment articles as many of these were summarizing the articles which were already included. We may have missed some potentially relevant literature that did not fit the search terms, although this was minimized by snowballing the references which were identified. The review is based on published research literature and excluded operational or programmatic reports and book chapters which may have added valuable insights. The heterogeneous nature of the papers identified meant that it was not possible for us to evaluate quality of publications or provide many quantitative findings. The papers identified, however, provided rich material for a comprehensive review of the ethical issues associated with uDCD.</p>
</sec>
<sec sec-type="conclusion" id="s6">
<title>Conclusion</title>
<p>uDCD &#x2013; or Organ Donation after Sudden Irreversible Cardiac Arrest (ODASICA) &#x2013; is a complex process which is unfamiliar to many; carefully considering the ethical issues involved at each stage is therefore critical. This review provides evidence of broad ethical consensus in many areas. Future protocols should acknowledge remaining areas of potential conflict and prospectively collect empirical evidence from relatives and clinicians to ensure greater understanding and transparency.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s7">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author Contributions</title>
<p>ZF conceived the study, and wrote the protocol with AG and IK. IK designed the search strategy and supported paper screening and retrieval. AG, ZF, and MI preformed the initial screening and analysis; WT contributed to the reruns of searches and analysis along with AG and MI. AG wrote the first draft of the methods and results, ZF the first draft of the introduction and discussion; WT provided the figures and tables, IK the PRISMA diagram. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded in part by NHSBT TF Grant TF093, and in part by the Wellcome Trust 208213/Z/17/Z. This work was part-funded by the Health Foundation&#x2019;s grant to the University of Cambridge for The Healthcare Improvement Studies (THIS) Institute (RG88620). THIS Institute is supported by the Health Foundation - an independent charity committed to bringing about better health and healthcare for people in the UK. NHSBT funded the work, but had no involvement in the conduct, analysis or write up of the research, The Wellcome Trust funded ZF.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI Statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s12">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontierspartnerships.org/articles/10.3389/ti.2025.13992/full#supplementary-material">https://www.frontierspartnerships.org/articles/10.3389/ti.2025.13992/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sque</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Balancing Hope and Despair at the End of Life: The Contribution of Organ and Tissue Donation</article-title>. <source>J Crit Care</source> (<year>2016</year>) <volume>32</volume>:<fpage>73</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcrc.2015.11.026</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="book">
<source>Overview &#x7c; Organ Donation for Transplantation: Improving Donor Identification and Consent Rates for Deceased Organ Donation &#x7c; Guidance &#x7c; NICE</source> <publisher-loc>England</publisher-loc>: <publisher-name>NICE</publisher-name> (<year>2011</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/cg135">https://www.nice.org.uk/guidance/cg135</ext-link> (Accessed December 23, 2024)</comment>.</citation>
</ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Mackie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aznar</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>J</given-names>
</name>
</person-group>. <source>Opt-Out System for Organ Donation</source> (<year>2018</year>).</citation>
</ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="book">
<collab>NHSBT</collab>. <source>Organ Donation and Transplantation: Activity Report 2019-20</source> (<year>2020</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.odt.nhs.uk/statistics-and-reports/annual-activity-report/">https://www.odt.nhs.uk/statistics-and-reports/annual-activity-report/</ext-link>
</comment> (<comment>Accessed November 28, 2024</comment>).</citation>
</ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal">
<article-title>Human Tissue Act 2004</article-title>. <source>Statute L Database</source> (<year>2004</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.legislation.gov.uk/ukpga/2004/30/contents">https://www.legislation.gov.uk/ukpga/2004/30/contents</ext-link> (Accessed February 21, 2024)</comment>.</citation>
</ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal">
<article-title>UK Guidelines on Transplantation from Deceased Donors after Circulatory Death</article-title>. <source>Br Transplant Soc</source> (<year>2023</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://bts.org.uk/transplantation-from-deceased-donors-after-circulatory-death/">https://bts.org.uk/transplantation-from-deceased-donors-after-circulatory-death/</ext-link> (Accessed February 21, 2024)</comment>.</citation>
</ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coll</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mi&#xf1;ambres</surname>
<given-names>E</given-names>
</name>
<name>
<surname>S&#xe1;nchez-Fructuoso</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fondevila</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Campo-Ca&#xf1;averal de la Cruz</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Dom&#xed;nguez-Gil</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Uncontrolled Donation after Circulatory Death: A Unique Opportunity</article-title>. <source>Transplantation</source> (<year>2020</year>) <volume>104</volume>(<issue>8</issue>):<fpage>1542</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000003139</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalle Ave</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Bernat</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Uncontrolled Donation after Circulatory Determination of Death: A Systematic Ethical Analysis</article-title>. <source>J Intensive Care Med</source> (<year>2018</year>) <volume>33</volume>(<issue>11</issue>):<fpage>624</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1177/0885066616682200</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>del R&#xed;o</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Andr&#xe9;s</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Padilla</surname>
<given-names>M</given-names>
</name>
<name>
<surname>S&#xe1;nchez-Fructuoso</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Molina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>&#xc1;</given-names>
</name>
<etal/>
</person-group> <article-title>Kidney Transplantation From Donors After Uncontrolled Circulatory Death: The Spanish Experience</article-title>. <source>Kidney Int</source> (<year>2019</year>) <volume>95</volume>(<issue>2</issue>):<fpage>420</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2018.09.014</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>S&#xe1;nchez-Fructuoso</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>P&#xe9;rez-Flores</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Del R\&#x2019;\io</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bl&#xe1;zquez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Calvo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>de la Higuera</surname>
<given-names>M&#xc1;</given-names>
</name>
<etal/>
</person-group> <article-title>Uncontrolled Donation after Circulatory Death: A Cohort Study of Data from a Long-Standing Deceased-Donor Kidney Transplantation Program</article-title>. <source>Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg</source> (<year>2019</year>) <volume>19</volume>(<issue>6</issue>):<fpage>1693</fpage>&#x2013;<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.15243</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delsuc</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Faure</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berthiller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dorez</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Matillon</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Meas-Yedid</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group> <article-title>Uncontrolled Donation after Circulatory Death: Comparison of Two Kidney Preservation Protocols on Graft Outcomes</article-title>. <source>BMC Nephrol</source> (<year>2018</year>) <volume>19</volume>:<fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/s12882-017-0805-1</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mateos-Rodr&#xed;guez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pardillos-Ferrer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Navalpotro-Pascual</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Barba-Alonso</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Martin-Maldonado</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Andr&#xe9;s-Belmonte</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Kidney Transplant Function Using Organs from Non-heart-beating Donors Maintained by Mechanical Chest Compressions</article-title>. <source>Resuscitation</source> (<year>2010</year>) <volume>81</volume>(<issue>7</issue>):<fpage>904</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.resuscitation.2010.04.024</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antoine</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Savoye</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gaudez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cheisson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Badet</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Videcoq</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Kidney Transplant from Uncontrolled Donation after Circulatory Death: Contribution of Normothermic Regional Perfusion</article-title>. <source>Transplantation</source> (<year>2020</year>) <volume>104</volume>(<issue>1</issue>):<fpage>130</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000002753</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghinolfi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Melandro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Torri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bindi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Biancofiore</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>The Role of Sequential Normothermic Regional Perfusion and End-Ischemic Normothermic Machine Perfusion in Liver Transplantation from Very Extended Uncontrolled Donation after Cardiocirculatory Death</article-title>. <source>Artif Organs</source> (<year>2023</year>) <volume>47</volume>(<issue>2</issue>):<fpage>432</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/aor.14468</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geraci</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Sepe</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>Non-heart-beating Organ Donation in Italy</article-title>. <source>Minerva Anestesiol</source> (<year>2011</year>) <volume>77</volume>(<issue>6</issue>):<fpage>613</fpage>&#x2013;<lpage>23</lpage>.</citation>
</ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoogland</surname>
<given-names>ERP</given-names>
</name>
<name>
<surname>Snoeijs</surname>
<given-names>MGJ</given-names>
</name>
<name>
<surname>Winkens</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Christaans</surname>
<given-names>MHL</given-names>
</name>
<name>
<surname>van Heurn</surname>
<given-names>LWE</given-names>
</name>
</person-group>. <article-title>Kidney Transplantation from Donors after Cardiac Death: Uncontrolled versus Controlled Donation</article-title>. <source>Am J Transpl</source> (<year>2011</year>) <volume>11</volume>(<issue>7</issue>):<fpage>1427</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2011.03562.x</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaspar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de Jesus</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Querido</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Damas</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Major Determinants of Primary Non Function from Kidney Donation after Maastricht II Circulatory Death: A Single Center Experience</article-title>. <source>J Crit Care</source> (<year>2024</year>) <volume>82</volume>:<fpage>154811</fpage>. <pub-id pub-id-type="doi">10.1016/j.jcrc.2024.154811</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pabisiak</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tejchman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ostrowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ciechanowski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sie&#x144;ko</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Rapid Access in Donation after Circulatory Death (DCD): The Single-Center Experience with a Classic Pathway in Uncontrolled DCD Algorithm</article-title>. <source>Transpl Proc</source> (<year>2022</year>) <volume>54</volume>(<issue>3</issue>):<fpage>595</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.transproceed.2021.11.036</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dupriez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>De Pauw</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Darius</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mourad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Penaloza</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Van Deynse</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Fourteen Years of Experience in Uncontrolled Organ Donation after Cardio-Circulatory Death</article-title>. <source>Transpl Proc</source> (<year>2014</year>) <volume>46</volume>(<issue>9</issue>):<fpage>3134</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.transproceed.2014.09.164</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reznik</surname>
<given-names>ON</given-names>
</name>
<name>
<surname>Skvortsov</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Daineko</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Loginov</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Kutenkov</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Komedev</surname>
<given-names>SS</given-names>
</name>
<etal/>
</person-group> <article-title>First Russian Experience in Liver and Kidney Transplantation from Donors with Out-Of-Hospital Cardiac Arrest: 3 Years&#x2019; Results</article-title>. <source>Russ J Transplantology Artif Organs</source> (<year>2021</year>) <volume>23</volume>(<issue>3</issue>):<fpage>35</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.15825/1995-1191-2021-3-35-49</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wall</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Norman</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Munjal</surname>
<given-names>KG</given-names>
</name>
<etal/>
</person-group> <article-title>Lesson from the New York City Out-Of-Hospital Uncontrolled Donation after Circulatory Determination of Death Program</article-title>. <source>Ann Emerg Med</source> (<year>2016</year>) <volume>67</volume>(<issue>4</issue>):<fpage>531</fpage>&#x2013;<lpage>7.e39</lpage>. <pub-id pub-id-type="doi">10.1016/j.annemergmed.2015.09.017</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Light</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>The Washington, D.C. Experience with Uncontrolled Donation after Circulatory Determination of Death: Promises and Pitfalls</article-title>. <source>J L Med Ethics J Am Soc L Med Ethics</source> (<year>2008</year>) <volume>36</volume>(<issue>4</issue>):<fpage>735</fpage>&#x2013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-720X.2008.00332.x</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Chueh</surname>
<given-names>SC</given-names>
</name>
<etal/>
</person-group> <article-title>Expanding the Donor Pool: Use of Renal Transplants from Non-heart-beating Donors Supported with Extracorporeal Membrane Oxygenation</article-title>. <source>Clin Transpl</source> (<year>2005</year>) <volume>19</volume>(<issue>3</issue>):<fpage>383</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0012.2005.00358.x</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Yim</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Kidney Transplantation from a Donor Following Cardiac Death Supported with Extracorporeal Membrane Oxygenation</article-title>. <source>J Korean Med Sci</source> (<year>2012</year>) <volume>27</volume>(<issue>2</issue>):<fpage>115</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3346/jkms.2012.27.2.115</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominguez-Gil</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Duranteau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mateos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nunez</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Cheisson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Corral</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>Uncontrolled Donation after Circulatory Death: European Practices and Recommendations for the Development and Optimization of an Effective Programme</article-title>. <source>Transpl Int</source> (<year>2016</year>) <volume>29</volume>(<issue>8</issue>):<fpage>842</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1111/tri.12734</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smalcova</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Havranek</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pokorna</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Franek</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Huptych</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kavalkova</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Extracorporeal Cardiopulmonary Resuscitation-Based Approach to Refractory Out-Of-Hospital Cardiac Arrest: A Focus on Organ Donation, a Secondary Analysis of a Prague OHCA Randomized Study</article-title>. <source>Resuscitation</source> (<year>2023</year>) <volume>193</volume>:<fpage>109993</fpage>. <pub-id pub-id-type="doi">10.1016/j.resuscitation.2023.109993</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wind</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Faut</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Smaalen</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>van Heurn</surname>
<given-names>EL</given-names>
</name>
</person-group>. <article-title>Variability in Protocols on Donation after Circulatory Death in Europe</article-title>. <source>Crit Care</source> (<year>2013</year>) <volume>17</volume>(<issue>5</issue>):<fpage>R217</fpage>. <pub-id pub-id-type="doi">10.1186/cc13034</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortega-Deballon</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hornby</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shemie</surname>
<given-names>SD</given-names>
</name>
</person-group>. <article-title>Protocols for Uncontrolled Donation After Circulatory Death: A Systematic Review of International Guidelines, Practices and Transplant Outcomes</article-title>. <source>Crit Care Lond Engl</source> (<year>2015</year>) <volume>19</volume>(<issue>1</issue>):<fpage>268</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-015-0985-7</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pimentel</surname>
<given-names>SQ</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>FJ</given-names>
</name>
</person-group>. <article-title>Use of Extracorporeal Membrane Oxygenation in Adult Patients during Cardiac Arrest</article-title>. <source>Int J Cardiovasc Sci</source> (<year>2024</year>) <volume>37</volume>. <pub-id pub-id-type="doi">10.36660/ijcs.2023193</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Artiles Medina</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Burgos Revilla</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>&#xc1;lvarez Nadal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muriel Garc&#xed;a</surname>
<given-names>A</given-names>
</name>
<name>
<surname>&#xc1;lvarez D&#xed;az</surname>
<given-names>N</given-names>
</name>
<name>
<surname>G&#xf3;mez Dos Santos</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>Comparison of In Situ Preservation Techniques for Kidneys From Donors After Circulatory Death: A Systematic Review and Meta-Analysis</article-title>. <source>Transl Androl Urol</source> (<year>2021</year>) <volume>10</volume>(<issue>8</issue>):<fpage>3286</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.21037/tau-21-236</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Effects of Machine Perfusion Strategies on Different Donor Types in Liver Transplantation: A Systematic Review and Meta-Analysis</article-title>. <source>Int J Surg Lond Engl</source> (<year>2023</year>) <volume>109</volume>(<issue>11</issue>):<fpage>3617</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1097/JS9.0000000000000661</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajsic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Treml</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Innerhofer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Eckhardt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Radovanovic Spurnic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Breitkopf</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Organ Donation from Patients Receiving Extracorporeal Membrane Oxygenation: A Systematic Review</article-title>. <source>J Cardiothorac Vasc Anesth</source> (<year>2024</year>) <volume>38</volume>(<issue>7</issue>):<fpage>1531</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1053/j.jvca.2024.03.020</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manara</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>O&#x2019;Callaghan</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Donation after Circulatory Death</article-title>. <source>Br J Anaesth</source> (<year>2012</year>) <volume>108</volume>:<fpage>i108</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/bja/aer357</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haase</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boffa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rudge</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Valero</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Ethical, Legal, and Societal Issues and Recommendations for Controlled and Uncontrolled DCD</article-title>. <source>Transpl Int</source> (<year>2016</year>) <volume>29</volume>(<issue>7</issue>):<fpage>771</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/tri.12720</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Jesus</surname>
<given-names>JE</given-names>
</name>
</person-group>. <article-title>Treatment of Potential Organ Donors in the Emergency Department: A Review</article-title>. <source>Ann Emerg Med</source> (<year>2012</year>) <volume>60</volume>(<issue>4</issue>):<fpage>485</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.annemergmed.2012.04.018</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Schears</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Padela</surname>
<given-names>AI</given-names>
</name>
</person-group>. <article-title>Donation after Cardiac Death and the Emergency Department: Ethical Issues</article-title>. <source>Acad Emerg Med</source> (<year>2014</year>) <volume>21</volume>(<issue>1</issue>):<fpage>79</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1111/acem.12284</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dom\&#x2019;&#x131;nguez-Gil</surname>
<given-names>B</given-names>
</name>
<name>
<surname>P&#xe9;rez-Villares</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Andr&#xe9;s</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Uncontrolled Donation after Circulatory Death: Ethics of Implementation</article-title>. <source>Curr Opin Organ Transpl</source> (<year>2019</year>) <volume>24</volume>(<issue>3</issue>):<fpage>358</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1097/MOT.0000000000000648</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dominguez-Gil</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Greer</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Manara</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Souter</surname>
<given-names>MJ</given-names>
</name>
</person-group>. <article-title>Organ Donation after Circulatory Death: Current Status and Future Potential</article-title>. <source>Intensive Care Med</source> (<year>2019</year>) <volume>45</volume>(<issue>3</issue>):<fpage>310</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-019-05533-0</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhury</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Prins</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Yoeli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nydam</surname>
<given-names>TL</given-names>
</name>
</person-group>. <article-title>Uncontrolled Deceased Cardiac Donation: An Unutilized Source for Organ Transplantation in the United States</article-title>. <source>Clin Transpl</source> (<year>2019</year>) <volume>33</volume>(<issue>3</issue>):<fpage>e13474</fpage>. <pub-id pub-id-type="doi">10.1111/ctr.13474</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Graca</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Borries</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Polk</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Testa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wall</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Ethical Issues in Donation Following Circulatory Death: A Scoping Review Examining Changes over Time from 1993 to 2022</article-title>. <source>AJOB Empir Bioeth</source> (<year>2023</year>) <volume>14</volume>(<issue>4</issue>):<fpage>237</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1080/23294515.2023.2224590</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thiessen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wall</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>The Ethics of Donation After Circulatory Death Organ Recovery: An Overview of New Considerations Arising From Procurement Practice and Policy Changes</article-title>. <source>Curr Opin Organ Transpl</source> (<year>2023</year>) <volume>28</volume>(<issue>2</issue>):<fpage>133</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/MOT.0000000000001046</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koukoura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tsianos</surname>
<given-names>GI</given-names>
</name>
<name>
<surname>Gargavanis</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Vassiliadis</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Organ Donation in the US and Europe: The Supply vs Demand Imbalance</article-title>. <source>Transpl Rev</source> (<year>2021</year>) <volume>35</volume>(<issue>2</issue>):<fpage>100585</fpage>. <pub-id pub-id-type="doi">10.1016/j.trre.2020.100585</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Sandroni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grunau</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Parr</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Macneil</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Perkins</surname>
<given-names>GD</given-names>
</name>
<etal/>
</person-group> <article-title>Organ Donation after Out-Of-Hospital Cardiac Arrest: A Scientific Statement from the International Liaison Committee on Resuscitation</article-title>. <source>Resuscitation</source> (<year>2023</year>) <volume>190</volume>:<fpage>109864</fpage>. <pub-id pub-id-type="doi">10.1016/j.resuscitation.2023.109864</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastami</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matthes</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Krones</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Biller-Andorno</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Systematic Review of Attitudes toward Donation after Cardiac Death Among Healthcare Providers and the General Public</article-title>. <source>Crit Care Med</source> (<year>2013</year>) <volume>41</volume>(<issue>3</issue>):<fpage>897</fpage>&#x2013;<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1097/CCM.0b013e31827585fe</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molina-P&#xe9;rez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Delgado</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Frunza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Randhawa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>de Wijdeven</surname>
<given-names>JRV</given-names>
</name>
<etal/>
</person-group> <article-title>Should the Family Have a Role in Deceased Organ Donation Decision-Making? A Systematic Review of Public Knowledge and Attitudes towards Organ Procurement Policies in Europe</article-title>. <source>Transpl Rev</source> (<year>2022</year>) <volume>36</volume>(<issue>1</issue>):<fpage>100673</fpage>. <pub-id pub-id-type="doi">10.1016/j.trre.2021.100673</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schou</surname>
<given-names>A</given-names>
</name>
<name>
<surname>M&#xf8;lgaard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Holm</surname>
<given-names>S</given-names>
</name>
<name>
<surname>S&#xf8;rensen</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Ethics in Extracorporeal Life Support: A Narrative Review</article-title>. <source>Crit Care</source> (<year>2021</year>) <volume>25</volume>:<fpage>256</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-021-03689-0</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiff</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Koziatek</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pomerantz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bosson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Parent</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Extracorporeal Cardiopulmonary Resuscitation Dissemination and Integration with Organ Preservation in the USA: Ethical and Logistical Considerations</article-title>. <source>Crit Care</source> (<year>2023</year>) <volume>27</volume>:<fpage>144</fpage>. <pub-id pub-id-type="doi">10.1186/s13054-023-04432-7</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Knight</surname>
<given-names>C</given-names>
</name>
</person-group> <article-title>Reflective Equilibrium</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Zalta</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Nodelman</surname>
<given-names>U</given-names>
</name>
</person-group>, editors. <source>The Stanford Encyclopedia of Philosophy. Winter 2023</source>. <publisher-name>Metaphysics Research Lab, Stanford University</publisher-name> (<year>2023</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://plato.stanford.edu/archives/win2023/entries/reflective-equilibrium/">https://plato.stanford.edu/archives/win2023/entries/reflective-equilibrium/</ext-link> (Accessed December 16, 2024)</comment>.</citation>
</ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ives</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>A Method of Reflexive Balancing in a Pragmatic, Interdisciplinary and Reflexive Bioethics</article-title>. <source>Bioethics</source> (<year>2014</year>) <volume>28</volume>(<issue>6</issue>):<fpage>302</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1111/bioe.12018</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ives</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Molewijk</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schildmann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>B&#xe6;r&#xf8;e</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Frith</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group> <article-title>Standards of Practice in Empirical Bioethics Research: Towards a Consensus</article-title>. <source>BMC Med Ethics</source> (<year>2018</year>) <volume>19</volume>(<issue>1</issue>):<fpage>68</fpage>. <pub-id pub-id-type="doi">10.1186/s12910-018-0304-3</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMillan</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Good Medical Ethics</article-title>. <source>J Med Ethics</source> (<year>2018</year>) <volume>44</volume>(<issue>8</issue>):<fpage>511</fpage>&#x2013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1136/medethics-2018-105041</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tricco</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Lillie</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zarin</surname>
<given-names>W</given-names>
</name>
<name>
<surname>O&#x2019;Brien</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Colquhoun</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Levac</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation</article-title>. <source>Ann Intern Med</source> (<year>2018</year>) <volume>169</volume>(<issue>7</issue>):<fpage>467</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.7326/M18-0850</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pham</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Raji&#x107;</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Greig</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Sargeant</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>SA</given-names>
</name>
</person-group>. <article-title>A Scoping Review of Scoping Reviews: Advancing the Approach and Enhancing the Consistency</article-title>. <source>Res Synth Methods</source> (<year>2014</year>) <volume>5</volume>(<issue>4</issue>):<fpage>371</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1002/jrsm.1123</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldsmith</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Using Framework Analysis in Applied Qualitative Research</article-title>. <source>Qual Rep</source> (<year>2021</year>) <volume>26</volume>(<issue>6</issue>):<fpage>2061</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.46743/2160-3715/2021.5011</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doig</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Zygun</surname>
<given-names>DA</given-names>
</name>
</person-group>. <article-title>(Uncontrolled) Donation After Cardiac Determination of Death: A Note of Caution</article-title>. <source>J L Med Ethics J Am Soc L Med Ethics</source> (<year>2008</year>) <volume>36</volume>(<issue>4</issue>):<fpage>760</fpage>&#x2013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-720X.2008.00335.x</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rady</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>McGregor</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Verheijde</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Mass Media Campaigns and Organ Donation: Managing Conflicting Messages and Interests</article-title>. <source>Med Health Care Philos</source> (<year>2012</year>) <volume>15</volume>(<issue>2</issue>):<fpage>229</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/s11019-011-9359-3</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volk</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>GJW</given-names>
</name>
<name>
<surname>Anspach</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Couper</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Merion</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Ubel</surname>
<given-names>PA</given-names>
</name>
</person-group>. <article-title>Attitudes of the American Public toward Organ Donation after Uncontrolled (Sudden) Cardiac Death</article-title>. <source>Am J Transpl</source> (<year>2010</year>) <volume>10</volume>(<issue>3</issue>):<fpage>675</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2009.02971.x</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goudet</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Albouy-Llaty</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Migeot</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pain</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dayhot-Fizelier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pinsard</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Does Uncontrolled Cardiac Death for Organ Donation Raise Ethical Questions? An Opinion Survey</article-title>. <source>Acta Anaesthesiol Scand</source> (<year>2013</year>) <volume>57</volume>(<issue>10</issue>):<fpage>1230</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/aas.12179</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parent</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Caplan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Angel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kon</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Dubler</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Goldfrank</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group> <article-title>The Unique Moral Permissibility of Uncontrolled Lung Donation after Circulatory Death</article-title>. <source>Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg</source> (<year>2020</year>) <volume>20</volume>(<issue>2</issue>):<fpage>382</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.15603</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Oniscu</surname>
<given-names>GC</given-names>
</name>
</person-group>. <article-title>Piloting Uncontrolled DCD Organ Donation in the UK; Overview, Lessons and Future Steps</article-title>. <source>Curr Transpl Rep</source> (<year>2022</year>) <volume>9</volume>(<issue>4</issue>):<fpage>250</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s40472-022-00374-1</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalle</surname>
<given-names>AAL</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Gardiner</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Extracorporeal Membrane Oxygenation (ECMO) Assisted Cardiopulmonary Resuscitation or Uncontrolled Donation after the Circulatory Determination of Death Following Out-Of-Hospital Refractory Cardiac Arrest&#x2014;An Ethical Analysis of an Unresolved Clinical Dilemma</article-title>. <source>Resuscitation</source> (<year>2016</year>) <volume>108</volume>:<fpage>87</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.resuscitation.2016.07.003</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giannini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Abelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Azzoni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Biancofiore</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Citterio</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Geraci</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Why Can&#x2019;t I Give You My Organs after My Heart Has Stopped Beating?&#x2019; an Overview of the Main Clinical, Organisational, Ethical and Legal Issues Concerning Organ Donation after Circulatory Death in Italy</article-title>. <source>Minerva Anestesiol</source> (<year>2016</year>) <volume>82</volume>(<issue>3</issue>):<fpage>359</fpage>&#x2013;<lpage>68</lpage>.</citation>
</ref>
<ref id="B63">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verheijde</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Rady</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>McGregor</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Presumed Consent for Organ Preservation in Uncontrolled Donation After Cardiac Death in the United States: A Public Policy With Serious Consequences</article-title>. <source>Philos Ethics Humanit Med PEHM</source> (<year>2009</year>) <volume>4</volume>:<fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/1747-5341-4-15</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prabhu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>DeVita</surname>
<given-names>MA</given-names>
</name>
</person-group>. <article-title>Caring for Patients or Organs: New Therapies Raise New Dilemmas in the Emergency Department</article-title>. <source>Am J Bioeth AJOB</source> (<year>2017</year>) <volume>17</volume>(<issue>5</issue>):<fpage>6</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1080/15265161.2017.1299239</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munjal</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Wall</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Goldfrank</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Dubler</surname>
<given-names>NN</given-names>
</name>
<etal/>
</person-group> <article-title>A Rationale in Support of Uncontrolled Donation after Circulatory Determination of Death</article-title>. <source>Hastings Cent Rep</source> (<year>2013</year>) <volume>43</volume>(<issue>1</issue>):<fpage>19</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1002/hast.113</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wall</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Yushkov</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>JE</given-names>
</name>
<etal/>
</person-group> <article-title>Derivation of the Uncontrolled Donation after Circulatory Determination of Death Protocol for New York City</article-title>. <source>Am J Transpl</source> (<year>2011</year>) <volume>11</volume>(<issue>7</issue>):<fpage>1417</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2011.03582.x</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wall</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Munjal</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Dubler</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Goldfrank</surname>
<given-names>LR</given-names>
</name>
</person-group>
<collab>NYC uDCDD Study Group</collab>. <article-title>Uncontrolled Organ Donation after Circulatory Determination of Death: US Policy Failures and Call to Action</article-title>. <source>Ann Emerg Med</source> (<year>2014</year>) <volume>63</volume>(<issue>4</issue>):<fpage>392</fpage>&#x2013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.annemergmed.2013.10.014</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernat</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Bleck</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Blosser</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Bratton</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Capron</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Cornell</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Circulatory Death Determination in Uncontrolled Organ Donors: A Panel Viewpoint</article-title>. <source>Ann Emerg Med</source> (<year>2014</year>) <volume>63</volume>(<issue>4</issue>):<fpage>384</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.annemergmed.2013.05.018</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirby</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Is There a Particular Ethical Practice and Policy Space in North America for Uncontrolled Kidney Donation after Circulatory Death?</article-title> <source>J L Med Ethics J Am Soc L Med Ethics</source> (<year>2017</year>) <volume>45</volume>(<issue>1</issue>):<fpage>142</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1177/1073110517703108</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Arias</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tortosa</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Burant</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Aubert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Aulisio</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Youngner</surname>
<given-names>SJ</given-names>
</name>
</person-group>. <article-title>One or Two Types of Death? Attitudes of Health Professionals towards Brain Death and Donation after Circulatory Death in Three Countries</article-title>. <source>Med Health Care Philos</source> (<year>2013</year>) <volume>16</volume>(<issue>3</issue>):<fpage>457</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1007/s11019-011-9369-1</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Othman</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kondziella</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Public Opinion and Legislations Related to Brain Death, Circulatory Death and Organ Donation</article-title>. <source>J Neurol Sci</source> (<year>2020</year>) <volume>413</volume>:<fpage>116800</fpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2020.116800</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dailey</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Geary</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Merrill</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eijkholt</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Enabling Donation after Cardiac Death in the Emergency Department: Overcoming Clinical, Legal, and Ethical Concerns</article-title>. <source>J Emerg Med</source> (<year>2017</year>) <volume>52</volume>(<issue>4</issue>):<fpage>588</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.jemermed.2016.11.025</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>van</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>Ethical Considerations in the Use of Pre-mortem Interventions to Support Deceased Organ Donation: A Scoping Review</article-title>. <source>Transpl Rev</source> (<year>2021</year>) <volume>35</volume>(<issue>4</issue>):<fpage>100635</fpage>. <pub-id pub-id-type="doi">10.1016/j.trre.2021.100635</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonnie</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dineen</surname>
<given-names>KK</given-names>
</name>
</person-group>. <article-title>Legal Authority to Preserve Organs in Cases of Uncontrolled Cardiac Death: Preserving Family Choice</article-title>. <source>J L Med Ethics J Am Soc L Med Ethics</source> (<year>2008</year>) <volume>36</volume>(<issue>4</issue>):<fpage>741</fpage>&#x2013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-720X.2008.00333.x</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruce</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>MacDougall</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Are the Public Ready for Organ Donation after Out of Hospital Cardiac Arrest?</article-title> <source>Emerg Med J</source> (<year>2013</year>) <volume>30</volume>(<issue>3</issue>):<fpage>226</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1136/emermed-2012-201135</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeiler</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Furberg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tufveson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Welin</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>The Ethics of Non-heart-beating Donation: How New Technology Can Change the Ethical Landscape</article-title>. <source>J Med Ethics</source> (<year>2008</year>) <volume>34</volume>(<issue>7</issue>):<fpage>526</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/jme.2007.021568</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortega-Deballon</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Arias</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Uncontrolled DCD: When Should We Stop Trying to Save the Patient and Focus on Saving the Organs?</article-title> <source>Hastings Cent Rep</source> (<year>2018</year>) <volume>48</volume>(<issue>Suppl. 4</issue>):<fpage>S33</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1002/hast.950</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>DuBois</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Waterman</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Iltis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Is Rapid Organ Recovery a Good Idea? An Exploratory Study of the Public&#x2019;s Knowledge and Attitudes</article-title>. <source>Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg</source> (<year>2009</year>) <volume>9</volume>(<issue>10</issue>):<fpage>2392</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2009.02760.x</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borry</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Van Reusel</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Roels</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schotsmans</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Donation After Uncontrolled Cardiac Death (uDCD): A Review of the Debate From a European Perspective</article-title>. <source>J L Med Ethics J Am Soc L Med Ethics</source> (<year>2008</year>) <volume>36</volume>(<issue>4</issue>):<fpage>752</fpage>&#x2013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-720X.2008.00334.x</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Lora</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>What Does &#x2018;presumed Consent&#x2019; Might Presume? Preservation Measures and Uncontrolled Donation after Circulatory Determination of Death</article-title>. <source>Med Health Care Philos</source> (<year>2014</year>) <volume>17</volume>(<issue>3</issue>):<fpage>403</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/s11019-014-9548-y</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moorlock</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Draper</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Proposal to Support Making Decisions about the Organ Donation Process</article-title>. <source>J Med Ethics</source> (<year>2023</year>) <volume>49</volume>(<issue>6</issue>):<fpage>434</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/jme-2022-108323</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wind</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Mook</surname>
<given-names>WNKA</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>MEC</given-names>
</name>
<name>
<surname>van Heurn</surname>
<given-names>LWE</given-names>
</name>
</person-group>. <article-title>Higher Organ Donation Consent Rates by Relatives of Potential Uncontrolled Donors versus Potential Controlled Donors after Death</article-title>. <source>Nephrol Dial Transpl</source> (<year>2012</year>) <volume>27</volume>(<issue>11</issue>):<fpage>4219</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1093/ndt/gfs300</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Arias</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ortega-Deballon</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Youngner</surname>
<given-names>SJ</given-names>
</name>
</person-group>. <article-title>Casting Light and Doubt on Uncontrolled DCDD Protocols</article-title>. <source>Hastings Cent Rep</source> (<year>2013</year>) <volume>43</volume>(<issue>1</issue>):<fpage>27</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1002/hast.128</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84.</label>
<citation citation-type="web">
<collab>General Medical Council</collab>. <article-title>Good Medical Practice</article-title> (<year>2024</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.gmc-uk.org/professional-standards/professional-standards-for-doctors/good-medical-practice">https://www.gmc-uk.org/professional-standards/professional-standards-for-doctors/good-medical-practice</ext-link> (Accessed January 4, 2024)</comment>.</citation>
</ref>
<ref id="B85">
<label>85.</label>
<citation citation-type="book">
<source>Mental Capacity Act 2005</source>. <publisher-loc>England and Wales</publisher-loc>: <publisher-name>Statute Law Database</publisher-name>. (<year>2024</year>). <comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.legislation.gov.uk/ukpga/2005/9/contents">https://www.legislation.gov.uk/ukpga/2005/9/contents</ext-link> (Accessed January 4, 2024)</comment>
</citation>
</ref>
<ref id="B86">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedenko</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Nisihara</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yokoi</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Candido</surname>
<given-names>Vde M</given-names>
</name>
<name>
<surname>Galina</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Moriguchi</surname>
<given-names>RM</given-names>
</name>
<etal/>
</person-group> <article-title>Analysis of Knowledge of the General Population and Health Professionals on Organ Donation after Cardiac Death</article-title>. <source>Rev Bras Ter Intensiva</source> (<year>2016</year>) <volume>28</volume>(<issue>3</issue>):<fpage>285</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.5935/0103-507X.20160043</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perkins</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Lockey</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>de Belder</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Weissberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> <article-title>National Initiatives to Improve Outcomes from Out-Of-Hospital Cardiac Arrest in England</article-title>. <source>Emerg Med J EMJ</source> (<year>2016</year>) <volume>33</volume>(<issue>7</issue>):<fpage>448</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1136/emermed-2015-204847</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pybus</surname>
<given-names>EM</given-names>
</name>
</person-group>. <article-title>False Dichotomies: Right and Good</article-title>. <source>Philosophy</source> (<year>1983</year>) <volume>58</volume>(<issue>223</issue>):<fpage>19</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1017/s0031819100056230</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hornby</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dhanani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shemie</surname>
<given-names>SD</given-names>
</name>
</person-group>. <article-title>Update of a Systematic Review of Autoresuscitation after Cardiac Arrest</article-title>. <source>Crit Care Med</source> (<year>2018</year>) <volume>46</volume>(<issue>3</issue>):<fpage>e268</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1097/CCM.0000000000002920</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zorko</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Shemie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hornby</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Matheson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sandarage</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Autoresuscitation After Circulatory Arrest: An Updated Systematic Review</article-title>. <source>Can J Anaesth J Can Anesth</source> (<year>2023</year>) <volume>70</volume>(<issue>4</issue>):<fpage>699</fpage>&#x2013;<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1007/s12630-023-02411-8</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hornby</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hornby</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shemie</surname>
<given-names>SD</given-names>
</name>
</person-group>. <article-title>A Systematic Review of Autoresuscitation after Cardiac Arrest</article-title>. <source>Crit Care Med</source> (<year>2010</year>) <volume>38</volume>(<issue>5</issue>):<fpage>1246</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1097/CCM.0b013e3181d8caaa</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coggon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brazier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Quigley</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Best Interests and Potential Organ Donors</article-title>. <source>BMJ</source> (<year>2008</year>) <volume>336</volume>(<issue>7657</issue>):<fpage>1346</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.39575.561898.94</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Part</surname>
<given-names>2</given-names>
</name>
</person-group>. <article-title>Ethical Aspects of CPR and ECC</article-title>. <source>Circulation</source> (<year>2000</year>) <volume>102</volume>(<issue>Suppl. l_1</issue>):<fpage>I</fpage>&#x2013;<lpage>12</lpage>.</citation>
</ref>
<ref id="B94">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Truog</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Doernberg</surname>
<given-names>SN</given-names>
</name>
</person-group>. <article-title>In Defense of Normothermic Regional Perfusion</article-title>. <source>Hastings Cent Rep</source> (<year>2024</year>) <volume>54</volume>(<issue>4</issue>):<fpage>24</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/hast.4905</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Omelianchuk</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Capron</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Derse</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Bernat</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Magnus</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Neither Ethical Nor Prudent: Why Not to Choose Normothermic Regional Perfusion</article-title>. <source>Hastings Cent Rep</source> (<year>2024</year>) <volume>54</volume>(<issue>4</issue>):<fpage>14</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1002/hast.1584</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondziella</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>The Neurology of Death and the Dying Brain: A Pictorial Essay</article-title>. <source>Front Neurol</source> (<year>2020</year>) <volume>11</volume>:<fpage>736</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2020.00736</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rachels</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Active and Passive Euthanasia</article-title>. <source>N Engl J Med</source> (<year>1975</year>) <volume>292</volume>(<issue>2</issue>):<fpage>78</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM197501092920206</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Royo-Villanova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mi&#xf1;ambres</surname>
<given-names>E</given-names>
</name>
<name>
<surname>S&#xe1;nchez</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Manso</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ballesteros</surname>
<given-names>M&#xc1;</given-names>
</name>
<etal/>
</person-group> <article-title>Maintaining the Permanence Principle of Death during Normothermic Regional Perfusion in Controlled Donation after the Circulatory Determination of Death: Results of a Prospective Clinical Study</article-title>. <source>Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg</source> (<year>2023</year>). <pub-id pub-id-type="doi">10.1016/j.ajt.2023.09.008</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buster</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Trost</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Courtright-Lim</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ingall</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tilburt</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Toward Transparency and Trust: Assessing and Addressing Key Ethical Concerns in Normothermic Regional Perfusion</article-title>. <source>J L Med Ethics</source> (<year>2024</year>) <volume>52</volume>(<issue>1</issue>):<fpage>178</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1017/jme.2024.52</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Malley</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rainford</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Transparency During Public Health Emergencies: From Rhetoric to Reality</article-title>. <source>Bull World Health Organ</source> (<year>2009</year>) <volume>87</volume>(<issue>8</issue>):<fpage>614</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2471/blt.08.056689</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Rourke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Crowe</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gaffney</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Donation After Circulatory Death: A Narrative Review of Current Controversies, Attitudes, and the Evolving Role of Regional Perfusion Technology</article-title>. <source>AME Med J</source> (<year>2024</year>) <volume>9</volume>(<issue>0</issue>):<fpage>9</fpage>. <pub-id pub-id-type="doi">10.21037/amj-23-65</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>